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ABSTRACT 
The kidney responds to metabolic acidosis by the increased excretion 
of the ammonium salts of nonvolatile acids in the urine. It is therefore 
important to maintain an adequate supply of precursors of urinary am-
monia in order to maintain acid-base balance. In this work, arterio-
venous differences for all amino acids were measured across the kidneys 
of normal and acidotic rats to determine which amino acids were important 
in urinary ammonia production. Glutamine was the only amino acid taken 
up by the acidotic kidney; no amino acids were removed by the normal 
kidney. 
These measurements were made using whole blood since amino acid levels 
in whole blood and plasma were found to differ. Glycine, 
glutamate, lysine, and arginine were concentrated within the blood cells. 
In ~ddition, levels of serine, threonine and lysine rose and levels of 
glutamine fell in acidosis in both whole blood and plasma. \Vhole blood 
and plasma arterio-venous differences were measured for glutamine across 
the acidotic rat kidney. Results showed that glutamine is removed ex-
clusively from the plasma. 
In a further study on kidney metabolism, arteria-renal venous dif-
ferences for lactate were measured. Since both normal and acidotic 
kidney removed equivalent amounts of lactate, it was concluded that the 
oxidation of lactate carbon was not replaced by the oxidation of glutamine 
carbon in acidosis. 
The site of production of glutamine and the changes which occur in 
glutamine metabolism in response to an increased acid load were then in-
(ii) 
vestigated. To this end, measurements of the turnover rate of free 
glutamine in the body were made using both the single injection and con-
stant infusion methods. However, in order to obtain accurate estimates 
of the turnover rate, a technique for the measurement of the specific 
activity of l-14c-glutamine first had to be devised. Results obtained 
by both methods showed that the turnover rate of glutamine did not change 
in acidosis. This was taken to indicate that the extra glutamine re-
quired by the kidney in acidosis was supplied by a lessening of glutamine 
utilization by other tissues. Turnover values obtained by the single in-
jection method were considerably higher than those obtained by constant 
infusion. The pool size of glutamine calculated from the single in-
jection data was also considerably smaller than the total body glutamine 
pool obtained by analysis of whole body extracts and by a summation of 
data from other investigators. These differences were thought to be due 
to the methods used in the analysis of the single injection data. 
Arterio~venous differences for glutamine were measured across the 
major tissues of the body in order to determine the site of glutamine pro-
duction. Although glutamine was produced by the muscle of the normal 
rat, no significant output of glutamine by any tissue was found in 
acidosis. The kidneys and gastrointestinal tract removed glutamine 
during acidosis. Arterio-venous differences were also measured for 
glutamate to find if glutamate uptake paralleled glutamine output. 
However, glutamate was released by the muscle and brain of the normal rat 
and by the gastrointestinal tract of the acidotic rat; no uptake of 
glutamate was found. It thus appears that the glutamate required for 
glutamine synthesis does not come directly from the blood. 
(iii) 
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INTRODUCTION 
I. GENERAL 
A. Production of Metabolic Acid 
One of the most important physiological problems faced by animals 
is the maintainance of acid-base homeostasis. To achieve this end, 
animals must ultimately match their metabolic processes so that the 
overall result is neither the production nor the uptake of excess acid. 
Thus, .the oxidation of glucose to lactate: 
glucose--.. ~ 2 lactate- + 2H+ 
may be coupled to the oxidation of lactate to co2 and water: 
Similarly, the oxidation of fat to acetoacetate is normally coupled to 
the oxidation of acetoacetate to co2 and water: 
CH3 (cH2 ) 14coOH 502 
,. 4CH3ficH 2COO 
- 4H+ + + 
0 
CH3~cH2COO - + H+ + 402 t 3H20 + 4C02 t 
0 
However, the matching of metabolic processes to maintain neutrality is 
not always possible. For example, the production of co2 by the tissues 
actuaily results in the production of acid as long as the co2 produced 
remains in an aqueous environment: 
+ H 0 c. a:), H CO -;::='~ HC0-2 ~ 2 3'' 3 + 
The formation of carbonic acid from co2 and '
1
20 is catalyzed by the 
- 2 -
· ·· ... 
enzyme carbonic anhydrase (c.a.). co2 also reacts with undissociated 
aliphatic amino groups to form carbamino compounds with a concomitant 
production of acid: 
R-NH 2 + 
Thus, a small amount of co2 is bound to plasma proteins, this amount 
being of little consequence in the transport of co2 from the tissues. 
However, the increased pC02 of venous blood results in a three-fold 
increase in the amount of carbamino hemoglobin in venous blood which 
would significantly increase the acidity of the blood were it not for 
other considerations. 
Other mechanisms exist which produce excess acid in the body. The 
catabolism of sulfur-containing amino acids, including methionine and 
cystine, !esults in the production of sulfuric acid. Breakdown of 
orga~ically bound phosphate (e.g., phospholipid) causes the release of 
H2PO~ and a proton. 
B. Buffers of the Body 
Excess acid produced is buffered in the blood mainly by hemoglobin, 
the imidazole group of histidine residues being chiefly responsible 
for the buffering action. However, oxygenated hemoglobin (Hb02 ) is a 
stronger acid. than deoxygenated hemoglobin (Hb). Thus, not only is 
hemoglobin a good buffer when oxygenated, but when it loses its oxygen 
and picks up co2 , its buffering action is increased. In this way, the 
pH values of arterial and venous bloods usually differ by no more than 
0.03 pH units. 
- 3 - . 
The major buffer of the extracellular fluid . is the Hco;-H2co3 system 
which works mainly in conjunction with hemoglobin to maintain a constant 
body pH. Although the Hco;-H2co3 buffer system has a pKa of only 6.1, it 
is an effective buffer at physiological pH values, due to the constant 
pC02 (about 40 rom Hg) in the alveolar air. Thus, the [H2co3 ] is fixed 
by the constant pC02 and only the [HCO;J varies with any added acid or 
alkali. Thus, the log [Hco;J term of the Henderson-Hesselbalch 
H2co3 
equation (and consequently the pH) will not change as readily as it would 
for a buffer with no fixed components. The buffering efficiency of the 
Hco;-H2co3 system is further complemented by the presence of hemoglobin 
in erythrocytes. Since some acid is buffered by hemoglobin, more Hco; 
can remain in plasma and be available to buffer strong acids. 
C. Regulation of Hco;-H2 co3 System 
The pC02 of the air in the lungs is dependent on the rate and depth 
of respiration, which is controlled by a respiratory centre in the 
nervous system. This area has sensors which are sensitive to changes in 
the pH and pC02 of the extracellular fluid. Thus, a fall in pH of the 
extracellular fluid due to diminished [Hco;J causes a stimulation of 
respi~ation and consequently a lowering of aveolar pco2 . Hence, extra-
cellular [H2co3 ] is also lowered, and a rise in pH back to the normal of 
7.4 results. A rise in plasma pH or plasma [Reo;] causes the opposite 
effects. Pulmonary regulation of [H2co3 ] is extremel~ rapid although 
compensation is never complete, since a return of [H2co3 ] levels to normal 
- 4 - . 
r everses the effects on the respiratory centre. 
The kidney regulates the pH of body fluids by controlling the [Reo;] 
of the blood. Renal compensation requires longer periods of time than 
pulmonary compensation to be effective but may result in complete re-
s toration of normal pH and bicarbonate levels. A fall in pH due to in-
c reased aveolar co2 or decreased [Hco;J is counteracted by the excretion 
o f acidic urine which is buffered by ammonia. An increase in pH of the 
extracellular fluid results in the excretion of Na+, Hco; and the dis-
s ociated forms of other weak acids. Normally however the kidney reab-
s orbs 99.9% (some 5,100 meq/day in man) of the bicarbonate in the 
glomerular filtrate. Bicarbonate that was used to neutralize excess acid 
i n the blood is regenerated in the kidney tubular cells. 
The mechanism of reabsorption of bicarbonate, excretion of acid 
urine and excretion of ammonia is outlined in Fig. 1 and Fig. 2. 
According to this mechanism, carbonic acid generated within the cell by 
t he action of carbonic anhydrase (c.a.) dissociates to give bicarbonate 
i on and a proton. This proton is actively exchanged for a sodium ion in 
t he tubular urine. Sodium bicarbonate is then removed from the cell into 
the blood. Acid is then either excreted directly as phosphate salts 
(mainly NaH2Po4 ) (Fig. 2) called "titratable acidity" or is excreted in 
combination with ammonia, produced within the cell from amino acid pre-
cursors, designated in the figure, "X" (Fig. 1). Only a limited amount 
of titratable acid can be excreted, as the maximum u+ gradient attainable 
a cross the tubular cell membrane limits the pH of the urine to around 
4. 4. Also, the excretion of titratable acidity in large amounts would 
Tubular 
Urine 
Na+ 
Cl 
H + 
NH· 3 
! 
NH4+ 
+ 
Cl -
- 5 -
~ .. Cell 
. . 
Blood 
Na+ 
Na+ 
+ - HCO-H. , HC03 3 
1 ~ 
..,. 
H2 C03 
1 ~ 
H2 0-+ C02 
NH < X 3 
FIG. 1. Mechanism of the Excretion o f Ammonia. 
Tubu!ar 
Urine 
2 Na+ 
po= 
4 
H PO -,. N a 
2 4 
+ 
- 6 -
Cell Blood 
Na+ 
Na+ 
+ -H, HC03 Hco; 
1l 
HCO 
2 3 
1 ~ c. a. 
co + H 0 2 2 
FIG. 2. Mechanism of the Excretion uZ Titratable Acidity. 
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seriously deplete extracellular sodium supplies. Ammonia excreted in the 
urine thus salvages vital cations as well as neutralizes excess acid. 
Ammonia is thus an extremely important buffer of - urine acid but it 
is not a mechanism for the elimination of waste nitrogen in higher 
animals. It has several advantages that make it particularly suitable as 
a buffer in urine: (1) it is readily available through deamination and 
deamidation of amino acids and its formation does not directly utilize 
ATP, (2) in its unprotonated form (NH3), it is lipid soluble and readily 
diffuses across tubular cell membranes. In the acidic urine it becomes 
protonated (NH:) and is then lipid insoluble. This process whereby 
ammonia moves into the urine and is then trapped there is referred to as 
"diffusion trapping". 
D. Acidosis and Alkalosis 
Although normally the mechanisms that produce acid closely match 
those mechanisms that consume acid, the production of acid may be too 
great in certain circumstances. For example, in diabetes mellitus the 
breakdown of fats occurs very rapidly and leads to hepatic conversion 
of acetyl CoA to acetoacetic and B-hydroxybutyric acids (ketone bodies). 
A buildup of lactic acid in muscle may occur during severe exercise due 
to temporary oxygen deficiency. This buildup of nonvolatile strong acids 
in the blood may cause a lowering of blood pH and [Hco;J levels, a con-
dition referred to as metabolic acidosis. Metabolic acidosis may also 
be caused by a loss of bicarbonate from the intestine or via the kidneys 
during renal failure. Experimental acidosis is often attained by the ad-
- 8 -
•, 
ministration of acid by stomach tube, or more commonly, by the ingestion 
of NH4Cl. NH4 Cl dissociates to form ~3 and HCl, the ammonia being re-
moved by the liver to form urea. Metabolic alkalosis is characterized 
by a rise in pH due to buildup of alkali in the blood as may be caused by 
the metabolism of the anions of weak acids as found in fruits and 
vegetables, or by the ingestion of excess NaHC03 • 
Due to respiratory problems, alterations in [H2co3] may also occur 
which affect acid-base status. Pneumonia, pulmonary edema and other 
causes of respiratory difficulty may result in increased pco2 of aweolar 
air and a concomitant rise in [H2co3 ] and a lowering of plasma pH. 
Increased plasma [Hco;J then results due to buffering of H+ by hemo-
globin. Thus, a low plasma pH with both elevated [H2co3] and elevated 
[Hco;J is observed and this condition is referred to as respiratory 
acidosis. Conversely, respiratory alkalosis is a result of hyper-
ventilation of the lungs, causing a lower pco2 and [H2co3] and .thereby 
elevating pH. Since arterial pC02 is low, buffering of the H+ by 
hemoglobin automatically decreases plasma [Hco;J in an attempt at pre-
venting the rise in plasma pH. 
II. ~OURCES OF URINARY AMMONIA 
A. Important Amino Acid Precursors 
Since ammonia is such an important buffer in urine, allowing the ex-
cretion of acid with9ut the loss of vital cations, ~ts precursors and 
the source of its precursors are of great in :erest. At first it was be-
- 9 -
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lieved that ammonia removed by the kidney was preformed in blood. In 
1921, Nash and Benedict (54) produced the first evidence that ammonia 
preformed in the blood was not the major source of urinary ammonia. They 
cited low arterial levels of free NH3 , which remained unchanged in 
acidosis, alkalosis, and after nephrectomy, as well as a renal venous 
NH3 level that was twice as high as the arterial level. They thus con-
cluded that NH3 was formed within the kidney from nitrogenous precursors. 
Although they conceded that amino acids may be the precursors of urinary 
ammonia, they favored the idea that urea was the major precursor. 
It was not until 1943 that Van Slyke et al. (77) reported the first 
evidence that glutamine was the major precursor of urinary ammonia. 
Using the dog, kidneys were exteriorized to allow removal of blood samples 
from the renal vein without anaesthesia. They found that all urea re-
moved by the kidneys was excreted unchanged in the urine even during 
metabolic acidosis. Glutamine taken up did not appear in the urine. 
Glutamine was taken up in such amounts that the amide nitrogen alone 
could account for all of the ammonia put out in the renal vein as well 
as 60% of the ammonia in the urine. Glutamine extraction was decreased 
during infusion of NaHC03 , while glutamine administered to an acidotic 
dog markedly increased ammonia excretion. 
A different approach was used by Davies and Yudkin (22) to determine 
which amino acids were important in the production of urinary ammonia. 
Using rats made chronically acidotic (by feeding 0.05 M HCl) or 
alkalotic (by feeding 0.1 M NaHco3 ) for 3 to 8 months, ammonia production 
by kidney slices was measured using L-glutam~te, glycine, L-leucine, L-
a spartic acid or L-alanine. From these measurements, the involvement of 
· ... ~ .. 
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glutaminase, glycine oxidase, L-amino acid oxidase and the transaminase 
enzyme systems was inferred. These authors found increased ammonia 
production during acidosis and decreased ammonia production during 
alkalosis from L-glutamine, glycine and L-leucine, and no change in 
ammonia production from L-aspartate and L-alanine. They thus suggest 
that urinary ammonia is produced by deamination of glutamine, deamination 
of glycine by glycine oxidase, and deamination of other monoamino 
monocarboxylic acids by L-amino acid oxidase. 
Following the development of the automatic amino acid analyzer, 
Owen and Robinson (56) measured the extraction of amino acids by the 
human kidney. They found that glutamine was the major amino acid ex-
tracted by the normal kidney (47 + 14 ~moles/min); the extraction of 
glutamine by the kidney was greatly enhanced (102 + 53 ~moles/min) 
in ac idosis. The rate of glutamine extraction may not, however, 
account for all the ammonia produced by the kidney. If only the amide 
nitrogen of .glutamine was considered in ammonia production, only 63% 
of t he total NH3 production of the normal kidney and 74% of the total 
NH3 produced by the acidotic kidney could be accounted for. Small up-
takes of proline, glycine and possibly valine were thought to account 
for the balance of the NH3 produced by the normal kidney. These amino 
acids may also contribute to the ammonia production by the acidotic 
kidney. There was a substantial output of serine (30 + 27 ~moles/min) 
as well as outputs of alanine, cysteine and arginine by both normal and 
acidotic kidneys. However, while glutamate was released by the normal 
kidney, it was taken up by the acidotic kidney. It thus seems probable 
- 11 -
that the a-amino nitrogen of glutamine isused in the production of 
substantial amounts of ammonia by the acidotic human kidney while it 
may not contribute to ammonia production by the normal kidney. 
In the same year, Shalhoub ~ al. (71) measured arterio-venous dif-
ferences for some 23 amino acids in plasma across the kidneys of dogs. 
Acute metabolic acidosis was first induced in these animals by the ad-
ministration of 10 g NH4Cl orally for 3 days and then acute alkalosis 
was i nduced by intravenous infusion of 1% NaHco3 . Results were similar 
to t hose already described in man (56). In acidosis, glutamine plus 
asparagine (glutamine was not separated from asparagine by these authors), 
glycine, citrulline, tryptophan · and proline are extracted by the kidney 
while alanine, serine, glutamate, cystine and ornithine are added to the 
rena l venous plasma. The very low output of glutamate by the acidotic 
kidney suggest again that both the amide and a -amin o nitrogens of 
glutami ne are used in ammonia production during ac i dosis. When acute 
metabolic alkalosis was induced, the extraction of glutamine plus 
asparagine was halved, while the extraction of glycine and addition of 
serine and alanine remained unchanged. Thus, with the induction of 
acidosis in the dog as well as the human, increased e x traction and break-
down only of glutamine results in the greatly increased rate of ammonia 
excretion. 
Further experiments from the same laboratory (19) tested the effects 
of infusion of ammonia, amides and amino acids into one renal artery of 
the dog on the ammonia excretion of both kidfieys. Infusion of ammonium 
lactate into one renal artery resulted in increased ammonia output by that 
- 12 -
kidney . Infusion of glutamine, asparagine, alanine, leucine or glycine, 
however, resulted in increased ammonia excretion by both kidneys due to 
a significant buildup of the infused amino acid in the general cir-
culation. Previous experiments of this type have been summarized (10) and 
amino acids have been classified according to their potency for increasing 
urinary ammonia output. The physiological significance of these types 
of loading experiments is questionable due to the high concentrations of 
amino acids used. These high levels may cause amino acids to be 
utilized that would not normally be involved in ammonia production. 
This is borne out by experiments where infusion of D-amino acids resulted 
in increased ammonia production, while D-amino acids do not occur in 
signif icant amounts in the blood of animals. In addition, while alanine 
was found to contribute to urinary ammonia when administered in large 
amount s (19), in the intact animal (71) alanine is generally released 
by the kidney and thus cannot be an important precursor of urinary 
ammonia. 
Two years later, Pitts ~ al. (62) used a new technique to determine 
exactly which amino acids contribute to the production of ammonia in 
the acutely acidotic dog. They infused N15-labelled amino acids into 
the left renal artery of the dog and measured the production of N15 
ammonia by the left kidney. N15 ammonia produced by the right kidney was 
due to recirculated N15-label and was therefore subtracted from the 
N15 ammonia produced by the left kidney. From . these studies, it was 
determined that the amide of glutamine contributes 33 to 50% of urinary 
ammonia production, the a-amino nitrogen of plutamine contributes 16 to 
25%, the amino of glycine contributes 3.1 to 4.3% and the amino nitrogen 
- 13 -
of glutamate contributes 1.4 to 2.4%. The finding that the amino nitrogen 
of glutamate is not a good precursor of urinary ammonia although the 
amino nitrogen of glutamine is an important precursor is significant 
and consistent with previous in vivo studies. This may be due to either 
(1) a slow transport of glutamate into the mitochondria for deamination 
or (2) the possibility that glutamate is not produced in a free state 
following deamidation of glutamine, (3) the low physiological con-
centration of glutamate, although loading experiments have also shown 
glutamate to be ineffective in increasing urinary ammonia production. 
A major problem with the N15 method is due to the necessity for 
about 50 ~moles of ammonia for the satisfactory determination of N15 by 
mass spectrometry. Thus, elevated levels of some amino acids are re-
. d d ff. . . f N15 d . . Al h h qu1re to pro uce su 1c1ent ammon1a or eterm1nat1on. t oug 
infusion of N15 glutamine elevated arterial levels only 5-11%; the in-
fusions of glycine and glutamate had to be at such a rate as to elevate 
arterial levels by 25% and 186-223% respectively. Utilization of amino 
acids at such elevated levels may have no physiological significance 
as discussed previously for the loading experiments. Care must be taken 
also when estimating the pathway of breakdown of the amino acids. It may 
not be possible to decide if deamination occurs directly by L-amina 
acid oxidase, as many transaminases exist within the cell which can 
transfer the amino group to a keto acid to form the corresponding amino 
acid which can then undergo deamination to release ammonia. 
Work on the dog was continued by Addae and Lotspeich (2) who _ 
measured extrarenal glutamine arterio-venous differences. They found 
- 14 -
that in acute sulfuric acid acidosis there is increased extraction of 
glutamine by parts of the intestinal tract as well as the brain. The 
liver, which normally puts out glutamine, makes more glutamine in the 
acutely acidotic dog to maintain a constant or slightly elevated arterial 
glutamine level . They found no significant arterio-venous difference 
for glutamine across the hindlimb in either the normal or acidotic dog. 
Measurements of glutamine content of various tissues in the rat showed 
that while glutamine utilizing tissues had lowered glutamine levels, the 
liver of the rat showed increased glutamine content after NH4Cl ad-
ministration. Also citing the work of Duda and Handler (25) who showed 
15 that N -label injected as ammonium lactate first appeared in the liver 
glutamine fraction, Addae and Lotspeich proposed that the liver was the 
site of glutamine production in the rat as well as in the dog. 
The metabolism of selected amino acids by the kidney has been 
studied using the isolated perfused rat kidney (59). Using an artifical 
saline medium containing a single amino acid (one of alanine, glycine, 
leucine or aspartate) at 5 roM concentration, production of ammonia and 
glucose by the perfused kidney was measured. Pitts found increased 
ammonia production by the acidotic kidney from all four amino acids, and 
increased glucose production from alanine and aspartate. Using kidney 
cortex slices, increased activities of alanine aminotransferase and 
glutamate dehydrogenase were measured in the acidotic kidney. He thus 
suggested that alanine and aspartate may undergo transamination with a-
ketoglutarate to form glutamate before being deaminated. While his re-
sults are undoubtedly valid for the system studied they may have little 
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physiological significance. The presence of only one amino acid in such 
high concentrations will undoubtedly interrupt steady state metabolic 
levels. Experiments of this type are reminiscent of the loading ex-
periments previously discussed. 
The renal metabolism of amin~ acids was also investigated in fed 
and fasted pregnant sheep (13). There were significant outputs of 
glycine, serine, arginine and glutamine by the normal kidney and 
significant uptakes of alanine, aspartate, glutamate and citrulline. 
However, in 3-day fasted animals that were hypoglycemic, slightly 
acidotic, and excreting increased amounts of ammonia, glutamine was taken 
up and glutamate was put out by the kidney. Further studies (35) using 
both fed, starved and acidotic sheep showed that the acidotic sheep 
kidney also removes glutamine. The plasma glutamine level is decreased 
in acidosis and the authors report that "net peripheral release of 
glutamine tended to increase in acidotic and starved sheep", although no 
data were g.~ven. 
Recently, work on the metabolism of glutamine in normal and acidotic 
humans has been expanded (23). In agreement with the results of Owen 
and Robinson (56), these authors find that glutamine extraction by the 
normal kidney amply accounts for the ammonia produced by the kidney. 
In acidosis, glutamine extraction increases, but accounts for only 80% of 
the total ammonia production; the renal extraction of glutamate does not 
account for the balance. These authors find that the human forearm 
normally produces glutamine, and this production increases during 
acidosis. The liver, however, does not produce glutamine but releases 
J 
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glutamate into the circulation. 
B. Pathways of Ammonia Production 
The transfer of amino groufStO a-keto acids by transaminase enzymes 
has been mentioned briefly. The extent of contribution of this type of 
reaction to the production of urinary ammonia has not been established. 
There are two main pathways known for the breakdown of glutamine; 
namely the glutaminase I and glutaminase II pathways. The glutaminase 
II pathway is catalyzed by the sequential actions of two enzymes 
glutamine-ketoacid aminotransferase (GKA) and w-amidase: 
GKA glutamine + a-ketoacid ------)• a-ketoglutaramate + a-amino acid 
a-ketoglutaramate w-amidase a-ketoglutarate + NH3 
This system does not involve a true glutaminase reaction since the 
term glutaminase refers to an enzyme which directly converts gl_utamine 
+H2o to glutamate + NH3 . 
The glutaminase I pathway has been shown to be quantitatively the 
most important pathway of glutamine deamination (34). Glutaminase I has 
been characterized into phosphate dependent glutaminase (PDG) and 
phosphate independent glutaminase (PIG) both of which catalyze the 
breakdown of glutamine directly to glutamate and ammonia. Of these two 
isoenzymes, PDG is quantitatively the most importa~t and has been localized 
in the mitochondrialmatrix (42). PIG has been localized in the brush 
border of the kidney cortex cells (43). It has been shown (21, 75) not 
to be a true glutaminase but part of the y-glutamyl transpeptidase system. 
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Glutamate is the end product of the glutaminase I pathway and also of 
the glutaminase II pathway when a-ketoglutarate is the main a-keto acid 
involved. Glutamate formed by glutamine deamidation may serve as an im-
portant source of urinary ammonia by the action of glutamate dehydro-
gena s e (GDH), thus: 
GDH 
glutamate , a-ketoglutarate + 
N~H + 
III. RENAL LACTATE METABOLISM 
Leal-Pinto et al. (46) have studied the renal metabolism of lactate 
in t he alkalotic and acidotic dog. 14 By infusing C-lactate, they have 
determined that, in alkalosis, the contribution of lactate to production 
of co2 is twice as high as in acidosis, although the total production of 
C02 does not differ in the two acid-base states. More lactate was ex-
tracted from the renal arterial blood of the dog in alkalosis than in 
acidosis. This work, together with work done previously on the renal 
metabolism of glutamine carbon (63) suggests that lactate metabolism of 
the normal kidney is reduced during acidosis to allow the metabolism of 
the glutamine carbon which remains after ammonia production. 
Work .has also been done on the effect of acidosis on the metabolism 
of l actate by the perfused rat kidney (88). Lactate removal by kidneys 
of n ormal rats was stimulated by a reduction in perfusate pH to 7.1-7.2 
> 
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but no lower. However, kidneys from acutely acidotic rats (4-6 hours 
after oral NH4Cl administration) showed no increased lactate removal 
compared to kidneys from normal rats. From such a study as this, however, 
where rats were made acidotic for such a short time, any changes due to 
acidosis may not have had time to be established. As well, such in vitro 
experiments have questionable physiological validity when concentrations 
of substrates are 5-10 times higher than physiological levels. The ef-
fect of acidosis on lactate removal by the rat kidney is therefore still 
open to further investigation. 
IV . AMINO ACID TRANSPORT IN WHOLE BLOOD AND PLASMA 
Measurements of the transport and turnover of amino acids in the 
body are important in a study of the control of acid-base balance. 
Methods used to detect changes in amino acid levels effected by an organ 
(for example, measurements of arterio-venous differences) involve the 
measurement of amino acid levels in the blood perfusing that organ. The 
question arises as to whether whole blood or plasma should be used in 
such measurements; the latter being preferred, if possible, due to the 
ease of handling of plasma samples and high glutathione content of red 
cells which makes the determination of some amino acids in whole blood 
rather difficult. The following discussion will reveal, however, that 
whole blood measurements should be made when studying interorgan trans-
port of amino acids. 
(A) Experiments in vitro. 
The work up to the early 1960's on the i~ vitro transport of amino 
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acids between erythrocytes and plasma has been summarized by Winter and 
Christensen (84). Using human erythrocytes these authors tried to 
I 
characterize the effect of the structure of a neutral amino acid on its 
rate of transport across the erythrocyte membrane. They proposed three 
mechanisms for neutral amino acid uptake: (a) a mediated transport of 
neutral amino acids, especially those having long side chains, (b) a 
transporter of alanine and glycine that is of low capacity allowing slow 
transport of these amino acids and (c) a non-saturable component 
limited to amino acids with large hydrocarbon side chains. The charged 
amino acids studied such as glutamic acid and aspartic acid were taken up 
very slowly by the red cells. No data are reported for the transport of 
glutamine across the erythrocyte membrane. Similar work on the human 
erythrocyte has been reported (15). Uptakes of labelled glycine, 
tryptophan, lysine, phenylalanine and glutamic acid were very slow; 
equilibration of amino acids between erythrocyte and suspending medium 
. was still not obtained after 4 hours. 
Amino acid transport in sheep erythrocytes in vitro has also b·een 
investigated (87). These workers have studied the effects of different 
amino acids on L-alanine transport and have proposed that both the 
neutral and dibasic amino acids share a common transporter. 50 mM 
glutamine had no effect on L-alanine transport suggesting that glutamine 
is not transported by the same carrier in sheep erythrocytes. 
(B) Experiments in vivo. 
A number of papers have appeared in the literature concerning the 
transport of amino acids across the erythrocyte membrane in vivo. 
---
Pitts 
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et al. (61) reported arterio-venous differences across the dog kidney 
in acidosis and alkalosis using both whole blood and plasma. However, 
the results that were reported represent only one set of measurements 
made on a single dog making it impossible to draw statistically valid 
conclusions from t~ data. However, the arterio-venous difference 
(~m9les/ml) obtained for glutamine on plasma was approximately twice that 
obtained using whole blood, indicating that the red blood cell glutamine 
content is probably not available to the kidney. Later work by Elwyn 
(26, 28) on the dog demonstrated that differences exist in amino acid 
levels between plasma and whole blood in vivo, which are not altered by 
incubation of the blood withdrawn from the animal. This difference is 
illustrated by calculation of the distribution ratio which is the ratio of 
the blood cell to plasma levels. To represent equal distribution between 
cells and plasma this ratio would be 1.0 for the neutral amino acids and 
0.7 and 1.4 for the acidic and basic amino acids respectively que to Gibbs-
Donnan effects. However, the distribution ratios for most amino acids 
are always greater than 1 and also differ depending upon from which blood 
vessel the blood sample was taken. This is due in part to the large 
changes which occur in plasma amino acid levels and in some cases (e.g., 
glutamic acid) to opposite changes in the red blood cell levels. This 
indicates that in vivo transport of amino acids across the erythrocyte 
membrane can occur as the blood perfuses an organ. Changes also occur 
in red blood cell amino acid levels as a function of time, for which 
there are no corresponding changes in plasma. In his later report (27) 
Elwyn remarked on the rapid transfer of amino acids into and out of the 
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red blood cell that occurs as the blood passes through a capillary bed, 
indicating a rapid increase in the rate of transport of amino acids in 
vivo across the erythrocyte membrane into plasma. The implication from this 
is that some special mechanism for amino acid transport occurs in vivo, 
e.g., direct transfer of amino acids between erythrocytes and tissues. 
He suggests that the movement of amino acids between erythrocytes and 
plasma may be affected by hormones. 
Studies on amino acid transport by human erythrocytes in vivo were 
carried out by Aoki et al. (8). These investigators studied the effect 
of insulin on glutamate uptake by the huma~ forearm. They found that 
using plasma to measure arterio-venous differences, no increase in uptake 
of glutamate by muscle could be measured after infusion of insulin. If 
measurements were made using whole blood, however, a significant uptake 
of glutamate .could be measured after insulin treatment. In addition, in 
normal man, the arterio-venous difference for glutamate acros~ the 
forearm using plasma was found to be much greater than that measured 
using whole blood. Thus, in the normal case, glutamate moves into the 
red blood cell and muscle cell from the plasma, while in the presence of 
insulin, glutamate moves out of the red blood cell and plasma and into 
the muscle cells. It is therefore possible that hormones such as in-
sulin _may regulate amino acid movements across the erythrocyte membrane, 
although the mechanism fur this has not been postula~ed. 
Shortly afterwards, Aoki et al. (7) studied the plasma versus whole 
blood arterio-venous differences for all amino acids across the human 
forearm. There was an overall release of amino acids from muscle, 
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especially of glutamine, alanine, glycine, proline, threonine and lysine. 
The total release of amino acids measured using plasma (385 ~moles/1. 
plasma) was greater than the total amino acid release from whole blood 
(237 ~moles/1. blood) by a fraction which corresponded to the blood cell 
volume (hematocrit), indicating minimal blood cell:plasma interactions in 
the basal state. Following the ingestion of 200 g boiled beef, whole 
blood glutamine levels did not change, however, arterial blood cell 
glutamine levels increased. Thus, the blood cell/plasma glutamine ratio 
appears to be a function of the glutamine concentration in both com-
partments. 
These investigators also found differences between arterial blood 
cell and plasma amino acid levels; higher taurine, aspartate, glutamate, 
glycine, ornithine and lower proline, a-amino-n-butyrate, valine, 
isoleucine, leucine, phenylalanine, lysine and arginine levels were found 
in blood cells than in plasma. Work in this area was continued by 
Felig et al. (30). These investigators measured arterio-venous dif-
ferences for all amino acids across the leg and splanchnic bed of humans 
using both whole blood and plasma. They found higher levels of taurine, 
threonine, serine, citrulline, glycine, aspartate and alanine in whole 
blood than in plasma. Significant exchange of amino acids between 
tissues via the blood cells was calculated to occur for alanine, threonine, 
serine, methionine, leucine, isoleucine, tyrosine, and citrulline, since 
arterio-venous differences using whole blood were greater than arterio-
venous differences using plasma (both measured as ~moles/1. of whole 
blood). Glutamine uptake by the G.I.T. (arterial-portal venous difference) 
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u sing whole blood was much lower than that using plasma, indicating an 
uptake of glutamine by the blood cells as the blood perfuses the gut. 
Alanine was found to be the most important amino acid exchanged between 
organs accounting for 35-40% of the total amino acid flux from peripheral 
tissues and G.I.T. to the liver. Transport via blood cells accounts for 
22-32% of the total net movement of this amino acid. Windmueller and 
Spaeth (83) however have reported that preliminary experiments showed 
no equilibration of 14c glutamine between plasma and cells in a single 
pass through perfused intestine. 
These studies make it clear that the blood cellular elements may 
be important carriers in the net flux of amino acids between tissues, 
although transport of amino acids across the blood cell membrane in 
vitro is very slow. The mechanisms involved in amino acid transport by 
erythrocytes have yet to be elucidated. It is important, however, that 
in s t udies of amino acid flu~measurements using both whole blood and 
plasma be made. 
V. INTERORGAN TRANSPORT OF AMINO ACIDS IMPORTANT IN NITROGEN METABOLISM 
(A) Changes in Levels of Amino Acids with Altering Acid-Base 
Status. 
Changes in blood amino acid levels with changing acid base balance 
have been noted by some investigators. Shalhoub~ al. (71) measured 
arterio-renal venous differences in the dog for 23 amino acids using 
plasma. They report higher plasma arterial levels of glutamate, alanine, 
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serine, glycine, proline, threonine, histidine and arginine in acidosis 
than in alkalosis. However, as pointed out previously, these shifts in 
concentration could reflect a movement of amino acids into and out of red 
blood cells. Addae and Lotspeich (2) report elevated or unchanged levels 
of arterial plasma glutamine in acidosis compared to normal dogs. 
However, Owen and Robinson (56) note a fall in plasma glutamine during 
acidosis (P < .001) from a value of 65 + 7.5)Umoles/100 ml plasma in the 
normal to 40 + S)limoles/100 ml plasma in the acidotic human. Although 
a general lowering of most amino acid levels was observed in arterial 
plasma_ from 9 day acidotic humans, glutami?e was the only amino acid 
present in significantly decreased amounts. Felig et al. (29) have also 
reported a lowering of arterial plasma glutamine in diabetic patients 
[normal= 0.554 + .033 (S.E.) pmoles/ml; diabetic= 0.424 + .037 (S.E.) 
Fmoles/ml]. Weiss and Preuss (80) report acidotic arterial plasma 
glutamine levels of 0.68 + 0.02 (S.E.) Jlmoles/ml for the rat; ~o normal 
values were -reported. Welbourne (81) reports no significant difference 
from the normal levels of arterial plasma glutamine for rats made 
acidotic by replacing their drinking water with 1.5% NH4cl for 1 week 
[normal = 0.592 + 0.045 (S.E.) )Umoles/ml; NH4 Cl acidotic = 0.610 + 0.017 
(S.E.) pmoles/ml]. However, rats made acidotic by intraperitoneal in-
jecti9n of acetazolamide (an inhibitor of carbonic anhydrase) for 7 days 
showed a significant decrease in arterial plasma g~utamine (0.405 + 
.033;unoles/ml). Lund and Watford (51) presented data in a recent 
symposium that showed a significant decrease (P < .OS) in whole blood 
glutamine levels during chronic acidosis in rats. Heitman and Bergmann 
(35) also have recently reported that during acidosis and fasting 
plasma glutamine levels decrease in the sheep. 
(B) Measurements of Amino Acid Exchange In Vivo. 
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Numerous studies have been made on the exchange of amino acids 
between organ systems. Hil~~ al. (38) measured an output of glutamine 
by the hindlimb of mongrel dogs, greyhounds and spider monkeys. In-
fusion of ammonium salts was found to increase glutamine output, although 
ammonia uptake before infusion was not sufficient to account for the 
amide nitrogen of the released glutamine. There was also a significant 
glutamine output by the brain (arterial-external jugular venous dif-
ference). The G.I.T. (arterial-portal venous differences) as well as the 
kidneys remove glutamine. Animals studied were, however, starved for 
32 hr and glutamine was determined on plasma samples. These results 
contrast with the findings of Addae and Lotspeich (2) who studied glutamine 
metabolism in dogs in acute sulfuric acid acidosis. These workers find 
no glutamine output by the brain or hindleg of the normal dog; in the 
acutely acidotic dog, they find glutamine uptake by the brain. They also 
find that glutamine is produced by the liver, and that production in-
creases in acidosis. They suggest that the liver is the major site of 
glutamine production in the dog. 
Aikawa ~ al. (4), Matsutakaet al. (53) and Yamamoto et al. (86) 
have studied the interorgan transport of some amino acids in fed and 
starved rats. They found that alanine and glutamine accumulated to the 
greatest extent in the plasma after the G.I.T., liver, and kidneys were 
removed from the circulation. Others workers (16) have shown that 
- 26 -
alanine release can be decreased by stimulation of pyruvate dehydrogenase 
with dichloroacetate and by inhibition of alanine aminotransferase with 
cycloserine. Glutamine release was decreased by inhibition of glutamine 
synthetase with methionine sulfoximine. 
Arterio-venous difference measureillents made using plasma (4~ 53, 86) 
show that~ in the normal rat alanine and glycine are released by the 
muscle~ G.I.T. and kidneys. Glutamine is removed by the G.I.T. and the 
kidneys and put out by the splanchnic bed (liver+ G.I.T.). The liver 
removes alanine and glycine from the blood. Smaller transfers of lysine 
from the muscle to the liver and of serine from the kidneys to the G.I.T. 
were also measured. 
Glutamine is produced by the hindquarter of the starved rat (67). 
A large release of alanine and glutamine by muscle has been reported in 
postabsorptive and starved man (30, 52) and in normal and diabetic man 
(29 ). Outputs of these two amino acids are reported at 1.5 to 2 times 
their proportions in muscle. All workers have indicated that alanine is 
removed primarily by the splanchnic bed, while glutamine is removed by 
both the splanchnic bed and kidneys. Some authors (29) report also that 
transfer of glutamate o~curs from the splanchnic bed to muscle. It 
has been pointed out (65) that in the starved rat glutamine release from 
muscle is unchanged while alanine release increases tremendously. In rats 
where blood glucose has been lowered by injection of phloridzin (a 
subs tance which inhibits glucose absorption by the kidney), alanine re-
lease by muscle and extraction by the liver is increased. Glutamine has 
also been reported to be released by the brain in normal fed rats (50). 
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It thus appears, from the above studies in vivo, that alanine and 
glutamine are important nitrogen carriers in the blood. Alanine is 
apparently synthesized in the muscle by the transfer of nitrogen to 
pyruvate and is important in the transport of nitrogen to the splanchnic 
bed and as a gluconeogenic precursor. Glutamine is released by muscle 
and is important as a source of nitrogen in kidney metabolism. Since 
alanine and glutamine are released in such large amounts while the 
acidic and branched-chain amino acids are released in such small amounts, 
it appears that these latter amino acids provide the nitrogen for 
glutamine and alanine synthesis. 
(C) Measurements of Amino Acid Exchange In Vitro. 
Work carried outin vitro on amino acid metabolism has also demon-
strated the importance of alanine and glutamine as nitrogen carriers. 
These amino acids accounted for 50% of the total amino acids released in 
the perfused rat hindquarter (66, 67). Alanine release, but not glutamine 
release, was increased in perfused hindquarter from starved rats. 
Glutamine release and tissue glutamate levels were increased by addition of 
leucine to the perfusate. Addition of NH4Cl to the perfusate also in-
creased glutamine release. Similar results were obtained by other 
authors using an intact epitrochlaris muscle preparation (31, 32). They 
have also shown that other amino acids besides leucine can supply both 
the carbon and nitrogen for glutamine and alanine synthesis. It is thus 
apparent that, in the intact animal, glutamine and alanine are synthesized 
from other amino acids released by tissue catabolism. 
Glutamine metabolism by the G.I.T. has been studied in vitro using 
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perfused rat intestine (82, 83). Glutamine was removed from the per-
fusat e by preparations from normal and germ-free rats. Although 20% 
of the total plasma glutamine is removed in each pass of the blood 
through the intestine, a stable lower level of glutamine is normally 
maintained. This level is decreased by the addition of methionine 
sulfoximine, indicating that the intestine also synthesizes glutamine. 
The metabolism of glutamine occurs mainly in the small intestine mucosa 
and a ccounts for 30% of the total co2 produced by the preparation. The 
nitrogen from glutamine can be accounted for in germ-free rats by the 
ammonia, citrulline, alanine and proline released into the circulation. 
Glutamine removed from the ·lumen is metabolized in a similar fashion. 
Glutamine metabolism has also been studied in the isolated per-
fused rat liver. Net output of glutamine by the liver was greatest at 
pH 7 .15 due to a drastic decrease in glutamine catabolism (49). Other 
workers (76) have shown that at pH 6.9, glutamine production from 100 
+ 
mM NH4 and 10 mM alanine was increased. The physiological relevance of 
these studies is questionable, however, not only because of the high 
substrate levels involved, but because it has been shown (57) that blood 
pH v alues return to normal five days after the start of NH4cl ad-
ministration. Thus, changes in blood pH may play a role in the 
stimulation of hepatic glutamine production only in acute acidosis. 
A net uptake of glutamine has also been measured in the perfused 
rat liver (50) when glutamine levels in the perfusate were greater 
than 1 roM. These workers also found that ligation of both the portal 
vein and hepatic arteries in the intact rat, thus eliminating the 
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at pH 7.1 (36). In addit ion, kidney cortex slices from acidotic rats 
utilize more glutamine than do slices from normal rats (5). These workers 
have also found that prei~cubation of normal slices with acidotic 
plasma caused increased glutamine utilization by these slices, and have 
suggested that there i s a factor present in the plasma which causes 
increased ammonia product ion. Lotspeich (47) has reported than an in-
crease in kidney size occurs during acidosis in the dog. This may be 
important in increasin g t ne capacity of the animal to excrete excess 
acid during sustained metabolic acidosis. 
VI. MEASUREMENTS OF THE 'tURNOVER RATE OF GLUTAMINE 
A. Theory 
. Investigators have f ollowed two major approaches in using labelled 
substances in the measurement of turnover rates of metabolites. These 
involve the administration of the labelled compound as either a single 
inj ection or as ·a continuous infusion at a constant rate. The evolution 
of these techniques and t heir relative strengths and weaknesses have 
been reviewed by Hetenyi and Norwich (37). 
Zilversmit et al. (89, 90) derived a relationship whereby the turn-
over rate of a substance in a tissue (i.e., the amount of a substance 
that is turned over by that tissue per unit of time) could be calculated 
following a single injectiOn of that substance which has been labelled 
in some way.. Turnover ref ers to the removal of a substance, and may be 
due to transport of the substance out of the body pool and/or breakdown 
of that substance with subsequent release of label. Simplifying as-
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at pH 7.1 (36). In addition, kidney cortex slices from acidotic rats 
utilize more glutamine than do slices from normal rats (5). These workers 
have also found that preincubation of normal slices with acidotic 
plasma caused increased glutamine utilization by these slices, and have 
sugges ted that there is a factor present in the plasma which causes 
increased ammonia production. Lotspeich (47) has reported than an in-
creas e in kidney size occurs during acidosis in the dog. This may be 
important in increasing the capacity of the animal to excrete excess 
acid during sustained metabolic acidosis. 
VI. MEASUREMENTS OF THE TURNOVER RATE OF GLUTAMINE 
A. Theory 
Investigators have followed two major approaches in using labelled 
substances- in the measurement of turnover rates of metabolites. These 
involve the administration of the labelled compound as either a single 
injection or as a continuous infusion at a constant rate. The evolution 
of these techniques and their relative strengths and weaknesses have 
been reviewed by Hetenyi and Norwich (37). 
Zilversmit ~ al. (89, 90) derived a relationship whereby the turn-
over rate of a substance in a tissue (i.e., the amount of a substance 
that is turned over by that tissue per unit of time) could be calculated 
following a single injection of that substance which has been labelled 
in s ome way_. Turnover refers to the removal of a substance, and may be 
due to transport of the substance out of the body pool and/or breakdown 
of t hat substance with subsequent release of label. Simplifying as-
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s umptions made in the derivation of formulae are that the substance 
i s in a steady state (i.e., is at a constant concentration), having a 
c onstant rate of disappearance and appearance. Also, it is assumed that 
l abelled molecules react as do unlabelled molecules. Thus the specific 
a ctivity of that fraction of the total pool of the compound being 
broken down or leaving the body pool is equal to the specific activity of 
t he total amount of the compound present in the body pool. 
Thus, one can determine the turnover rate of a labelled substance in 
the . plasma by the following: 
Let B = the total amount of the substance present in the plasma, 
i.e., the pool size (moles) 
b the specific activity of the substance in the plasma (curies/ 
mole) 
v 1 the rate of disappearance of the substance from the plasma 
(moles/time) 
Using the following simple model consisting of the two compartments, 
plasma and all tissues which it perfuses, v 1 is the net flux of the 
substance out of the plasma 
Plasma Tissues 
Sp. act. b ~ vl , 
B moles ~ v2 ' 
The rate of change of radioactivity in the plasma is given as: 
d(bB) -V b 
dt 1 
db -v1 dt 
b ---B 
on integration,lnb 
-vl t + constant (1) 
B 
- 32 -
·. 
A plot of lnb versus t will thus have a slope of -v1 /B. The net 
flux out of the plasma v1 can thus be calculated if the pool size (B) 
is known. In practice this can be calculated if the amount of radio-
activity at time zero (Bb) injected into the plasma is accurately 
0 
known . A linear relationship is predicted between lnb and t by 
equation 1 and this is usually obtained after an initial multi-exponential 
decrease which is presumably due to mixing of the label throughout the 
body pool (Fig. 3). By extrapolation of the lnb vs t line back to 
zero time, one can calculate the "zero time specific activity (b ) 1', 
0 
i.e ., the specific activity the substance in the blood would be at 
zero time if instantaneous equilibration of label throughout the body 
pool occurred. Assuming the pool size did not change after the equili-
bration period, the calculated pool size at time zero (B ) is determined 
0 
fr om: 
B 
0 
(Bb) 
b 
0 
0 
This simple derivation does, however, have several drawbacks. First 
of all, no consideration is made for back-flow of labelled substances into 
the plasma or for resynthesis of labelled substances from labelled 
me tabolites. Howeve r, if a straight line is obtained for the lnb versus 
t plo~ it means that either that no re-entry of label into plasma has 
o ccurred or that re-entry of label has occurred at a constant rate. Thus, 
one obtains for the net flux a combination of v1 and v2 , that is, a com-
bination of the fluxes out of and back into the plasma. It is also 
apparent that the flux v1 is in fact a combination of an individual 
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FIG. 3. Single Injection Method for the Measurement of Glutamine Turnover. 
flux values for the substance into the various tissues (i.e., 
n 
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;£ V1.). It is very likely that the flux rate of a substance out of 
i = 1 1 · 
plasma into a tissue varies in different tissues. 
The measurement of the turnover rate (V1 ) was undertaken in this 
study in an attempt to detect changes in glutamine metabolism between 
normal and acidotic rats; in particular, I hoped to detect changes in the 
rate of synthesis and/or degradation of glutamine in extrarenal tissues 
of the acidotic rat which would provide the extra glutamine required by 
the acidotic kidney for urinary ammonia production. However, the change 
in the fractional part of v1 due to renal metabolism must be a sig-
nificant fraction of the total v1 for glutamine in order to detect any 
changes in v1 with altered acid-base status : 
The turnover rate of a substance may also be determined by a method 
based on the constant infusion of labelled substances. In this method 
the labelled substance is administered as a continuous infusion at a 
constant rate until the label has equilibrated throughout the body pool. 
After this point the label remains at a constant specific activity, i.e., 
at a plateau level. The rate of removal of label is then equal to the 
rate of infusion of label and the flux may be easily determined. 
In this derivatio~ the simple two compartment model is considered 
consisting of the plasma and all tissues which it perfuses. Labelled 
substance is infused into the plasma at a rate of V (moles/time) and 
s 
specific activity i (curies/mole). 
Plasma Tissues 
B-moles .~ vl sp. act. , 
sp. act. b J vz t 
~ 
v 
s 
Infuse at sp. act. i 
The rate of change of label in the plasma is given by: 
d(Bb) 
dt 
v i 
s + 
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When the label in the plasma is at a constant specific activity (i.e., 
at plateau) then, 
d(Bb) 
dt 
0 
assuming no backflow of label into the plasma (i.e., v 2 = 0) 
and 
v i 
s 
v i 
s 
b 
Vi is the rate of infusion of label (curies/time). As in most 
s 
tracer experiments, the mass of the labelled substance infused is assumed 
to be negligible in comparison to the amount of that substance in the 
body pool. No selective treatment of labelled molecules and no re-
synthesis of labelled molecules are assumed. The continuous infusion 
technique does not require accurately timed samples as does the single 
injection technique and it may thus be technically advantageous. 
The flux measured by both these techniques is a combination of component 
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fluxes into different tissues as well as the rate of degradation of 
labelled compound in these tissues. The pool size may thus be greater 
than the plasma and will include the amount of the substance in all 
tissues across which the label quickly equilibrates. The use of these 
techniques assumes that no recirculation of label (i.e., resynthesis of 
labelled glutamine) has occurred. This may have occurred in some 
tissues, notably the kidney which not only removes glutamine from the 
blood but contains an active glutamine synthetase. I hoped to minimize 
the resynthesis of labelled glutamine by using 14c-glutamine which was 
14 labelled in the !-carbon position. Thus, C label is released from 
glutamine after the breakdown of a-ketoglutarate to succinyl CoA (Fig. 
4) . 
B. Measurement of Turnover Rates Reported in the Literature 
The turnover rate of glutamine and other amino acids has been 
measured in intact animals and in various preparations in vitro. Duda 
and Handler (25) measured the turnover of glutamine in liver after the 
. . . f 1 . . d 15 . h bl d 1nJ eCt1on o g utam1ne-am1 e N 1nto t e oo . They obtained a value 
of 2.7 hours for the turnover time (i.e., the time it takes for the 
entire pool to turnover) which when taken with a measure d total body 
poo l of 1.25 mmoles, gave a value of 463pmoles/hr/300-400 g rat= 120-
150)lmoles/hr/100 g for the turnover rate of body glutamine. These 
values for turnover were obtained from the limiting slope of the log 
glutamine specific activity versus time curve as discussed in the pre-
vious section. In the calculation of the turnover rate given above it 
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·. 
is assumed that the 15N glutamine administered equilibrates with the 
total body glutamine pool. These authors also measured the rate of 
1 . h f 
15N h d · . . · f 15 g utam1ne synt esis rom H3 ; t e a m1n1strat1on o N ammonium 
lactate resulted in 80% of the label appearing in amide of glutamine. 
Thus, if NH3 liberated by glutamine breakdown was metabolized in the 
same manner as the exogenous ammonia load, 80% of the ammonia was re-
synthesized into glutamine. Thus, the real turnover time is about 1/5 
of the apparent value or approximately 0.54 hours. Thus, the turnover 
rate given by this method may be as high as 570 to 770)Umoles/hr/100 g 
body wt. However, this calculation assumes that the metabolism of 
endogenous ammonia in the liver occurs by the same route as an injected 
load of ammonium lactate. 
The turnover rate of glutamine has been measured in sheep (35) by 
constant infusion of u-14c glutamine. These authors have determined 
values of 12.2 + 0.7, 13.1 + 0.3 and 12.0 + 0.9 mmoles/hr for ~ed, 
NH4Cl acidotic and three day starved sheep. There appears to be little 
difference in glutamine turnover rates in these different states. 
Turnover rates for other amino acids have been measured by a number 
of authors. Waterlow and Stephen (79) have reported values for lysine 
turnover in the rat of approximately 180)Umoles/hr/100 g body wt. They 
have ~ompared this to values of 43, 18, 43 and 66)Umoles/hr/100 gob-
tained using valine, isoleucine, leucine and glycine respectively by 
other workers. Thus, most amino acids probably turnover at significantly 
lower rates than glu~amine. Glutamine turnover has also been determined 
in several -in vitro preparations. Windmuell ~r and Spaeth (82) have 
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measured the rate of glutamine utilization by the small intestine to 
be 179 nmoles/min/g tissue. Thus, intestine utilizes 75)lmoles/hr/ 
280 g rat or 27 )UIDOles/hr/100 g body wt. Using the turnover rate of 
Duda and Handler (25) of 120-150 pmoles/hr/100 g rat, 18-23% of the 
total rate of glutamine turnover is due to the utilization of glutamine 
by the small intestine . 
.... . · . 
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MATERIALS AND METHODS 
I • MATERIALS 
A. Reagents 
Chemicals used were of analytical grade or equivalent and were 
obtained from either J. T. Baker Chemical Co .• , Phillipsburg, N.J. or 
Fisher Sc±entific Co., Fair Lawn, N.J. All enzymes were obtained from 
Sigma Chemical Co., St. Louis, Missouri. 
B. Radioisotopes 
14 14 3 L-U C-glutamine, C-carboxy-dextran and H2o were obtained from 
New England Nuclear. L-114c-glutamic acid was obtained from Amersham 
Searle Corporation. L-114c-glutamine could not be obtained from any 
supplier and was thus synthesized as described later. The L-u14c 
glutamine was separated from possible breakdown products (glutamate and 
2-pyrrolidone-5-carboxylate) by the procedure of Adam and Simpson (1). 
Radiochemical purity was confirmed as described later. 
C. Animals 
Male Sprague-Dawley rats weighing 300-400 g used in all experiments, 
were obtained from Canadian Breeding Farms and Laboratories, St. Constant, 
La Prairie, Quebec. They were kept under continuous light conditions 
with free access to Purina Rat Chow (Ralston Purina of Canada, Ltd., 
Don Mills, Ontario) containing a minimum of 22.0% crude protein, a 
minimum of 4.0% crude fat, a maximum of 5.0% crude fiber as well as all 
necessary vitamins and mineral supplements. Water was given ad libitum 
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unless acidosis was to be induced when 1.5% NH4Cl was substituted for 
the drinking water for 7 to 10 days. After receipt of each shipment of 
animals~ they were conditioned in our own animal room, and given un-
limited food and water for at least one week prior to use. 
Previous experiments on the induction of ac i dosis in the rat (72) 
showed that when rats weighing less than 250 g were given 1.5% NH4Cl, 
they ate poorly and lost weight~ as well as having a lowered liver 
glycogen level. Therefore, in all experiments described here, rats 
weighing more than 250 g were used. Prior to measurements of arterio-
venous differences and in measurements of turnover rates, errors due 
to gross uptakes of amino acids from the G.I.T. were minimized by with-
holding food for four hours before the beginning of the experiment. 
Examination of the gut by dissection showed the gut to be almost empty 
when food was withheld for this length of time. 
II. MEASUREMENT OF ARTERIO-VENOUS DIFFERENCES 
A. Anaesthesia 
In early experiments, rats were anaesthesized by the intraperi-
toneal injection of sodium pentobarbital (6.5 mg/100 g body wt). However, 
when longer-acting anaesthesia was required, as in the experiments 
measuring the turnover rate of glutamine, inactin (0.1 ml of a 100 mg/ml 
solution in isotonic saline/100 g body wt) was injected intraperitoneally. 
(Inactin is the sodium salt of ethyl-(1 methyl-propyl)-malonyl-thiourea 
and was obtained from Henley and Co. Inc., N · ~w York, N.Y.) Small 
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additional doses of anaesthetic were administered if needed. 
Preliminary attempts were made at measuring the blood pressure of 
normal and acidotic rats using a tail cuff before and after inactin 
anaesthesia. Measurements on two normal animals showed no lowering of 
the blood pressure under inactin anaesthesia. Work by other investi-
gators who used inactin also showed a stable and normal blood pressure 
under inactin anaesthesia (55, 69, 74, 85). Presumably then, no 
detrimental effects on glomerular filtration rates were caused by inactin. 
Arterio-venous differences for glutamine across the kidney were 
also measured on both normal and acidotic rats under both sodium 
pentobarbital and inactin anaesthesia. Results showed that equivalent 
amounts of glutamine~e removed by the acidotic rat kidney when either 
anaesthetic was used. 
B. Blood Sampling 
Blood samples were taken, in different experiments, from the right 
external jugular vein, right femoral vein, hepatic portal vein and 
right renal vein using 26 gauge x 1/2" needles, from the hepatic vein 
using a 25 gauge x 1 1/2" needle bent to go over the liver and from the 
abdominal aorta using a 21 gauge x 1 1/2" short bevel needle. 1 ml 
or 5 ml syringes were attached and heparinized, if needed, by rinsing 
with a heparin solution (10,000 units/ml) obtained from M.T.C. 
Pharmaceuticals. The jugular vein was exposed by cutting away a small 
section of skin (1/2" x 1/2") with Mayo scissors and clearing by blunt 
dissection: The needle was placed in the vein so that the venous blood 
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was sampled coming from the direction of the brain. The abdominal 
vessels were exposed by a midline incision along the linea alba and traction 
I 
was applied, using wire hooks connected by rubber bands, to separate the 
edges of the incision. The vessels were cleared by blunt dissection and 
the appropriate needle inserted against the direction of blood flow, 
except the portal venous samples, which were withdrawn in the opposite 
direction due to technical considerations. In all experiments where a 
particular artery and vein were to be sampled, the venous sample was 
always withdrawn first, the needle left in place and the arterial 
sample then quickly taken. When the hepatic venous blood was to be 
sampled, a loose tie was first placed around the vena cava directly above 
the right renal vein. After all other venous samples were taken, the tie 
around the vena cava was tightened, the liver gently pulled away from 
the diaphr~to expose the hepatic vein and a bent needle was inserted to 
sample the hepatic venous blood. 
When plasma was to be prepared, the blood was taken into heparinized 
syringesand, when sufficient blood was taken, the needle was removed and 
the blood was transferred to Eppendorf micro test tubes. Thse were 
centrifuged at 12,000 x g for 2 min in an Eppendorf micro centrifuge 
(Brinkman Instruments Inc., Toronto) to separate the plasma from the 
blood cellular elements. 
C. Determination of Hematocrits. 
Hematocrits were determined on arterial blood samples from normal 
and acidotic rats. Blood samples were taken up into heparinized capillary 
tubes (1.2 mm x 75 mm), sealed, and centrifuged at top speed (5,000 x g) 
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in a clinical desktop centriguge (IEC Model CL) for 5 min. Hematocrits 
were then immediately estimated using a mi~rohematocrit tube reader 
(Sherwood Medical Industries Inc., Bridgeto~Mo.). Six different 
capillary tubes were filled with any particular sample and hematocrit 
values obtained were averaged. 
D. Preparation of Samples for Analysis of Amino Acids and Lactate 
Whole blood samples were deproteinized using an equal volume of 
6% HC104 while plasma samples were added to one-half volume of 12% 
HCl04 . These were kept on ice for at least 15 min or frozen overnight. 
Clear extracts were obtained by centrifugation. 
In earlier analyses which were performed using sodium citrate 
buffers, clear perchloric acid extracts were added to an equal volume of 
sodium citrate buffer (0.2 N in Na) pH 2.2 and sufficient NaOH was added 
to return the pH to 2-3. Amino acid analyses were then perfo~ed on 
these extracts. However, these techniques did not allow the separation 
of glutamine from asparagine. Later methods w~re developed using lithium 
citrate buffers which gave good separation of glutamine from asparagine. 
When these methods were used, perchloric acid extracts were added to an 
equal volume of lithium citrate buffer (0.3 N in Li, 0.1 N in citrate) 
pH 2.2. Sufficient LiOH was then added to return the pH to 2-3. 
Perchloric acid extracts to be assayed for lactate were adjusted to 
approximately pH 7 with KOH and the KC104 produced was removed by 
centrifugation. 
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E. Determination of Amino Acids and of Lactate 
In earlier experiments, amino acids were measured on a Beckman Model 
121 automatic amino acid analyzer. Two different types of analysis 
were performed, (a) the analysis of Benson and Patterson (12) to 
determine the full spectrum of amino acids without resolution of 
glu~amine from asparagine, and (b) the accelerated analysis of Benson 
et al. (11) to permit resolution of glutamine and asparagine. The fol-
lowing adaptations of the published methods were employed. In the 
analysis of acidic and neutral amino acids a 53 x 0.9 em column was 
employed, the sodium citrate buffers were changed at 185 min from pH 3.16 
(0.20 MinNa) to pH 4.25 (0.20 MinNa), the temperature change · time 
was 140 min and the total analysis time was 400 min. In the analysis 
of basic amino acids the first sodium citrate buffer was at pH 4.25 
(0.38 MinNa), the second buffer was at pH 5.36 (0.35 MinNa), the 
initial temperature was 30° C and the total analysis time was ~00 min. 
In the accelerated method for glutamine and asparagine, HP-AN-90 resin 
(Hamilton Co., Whittier, California) was employed in a 36 x 0.90 em 
column. The total analysis time was only 95 min since 10 min after the 
elution of glutaQine the run was ended. The column was then regenerated 
with 0.3 M LiOH, and equilibrated with the starting buffer. Using these 
methods it was possible to measure the amino acids without interference 
from glutathione. 
In later experiments, amino acid analyses were performed on the 
Beckman Model 121 amino acid analyzer by a single column lithium method 
which employed a DC-6A resin and the Durrum Pica Buffer System IV 
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(Durrum Chemical Corporation, Palo Alto, California). Some analyses 
were also performed on a Beckman Model 121 M amino acid analyzer as de-
scribed in Beckman Bulletin No. 121M- TBOOS (July, 1976). Use of this 
machine allowed the analysis of micro sample volumes and thus permitted 
the taking of numerous blood sample s from the same rat without seriously 
depleting its blood volume. 
Lactate was measured in deproteinized blood samples, previously 
adjusted to pH 7, by the method of Lowry and Passonneau (48). 
III . MEASUREMENTS OF TURNOVER RATES OF GLUTAMINE 
The turnover rate of L-114c-glutamine was measured in the intact 
rat by two methods; (1) constant infusion and (2) single injection. 
The experimental techniques involved in both methods were similar. In 
both techniques, l-14c-glutamine was administered via a jugular venous 
catheter and blood samples were withdrawn at timed intervals from a 
1 · 1 d · h · d R d · · · · 1 14c 1 · cannu a Lmp ante 1n t e carot1 artery. a 1oact1v1ty 1n - g utam1ne 
was then measured in these samples and the results used in the calculation 
of t urnover rates. 
A. Operative Procedure 
Rats were weighed and anaesthesized by intraperitoneal injection of 
inac tin (0.1 ml of 100 mg/ml solution in 0.9% NaCl/100 g body wt). The 
animal was then pinned to a wax board and the right external jug~lar vein 
was exposed by a small incision in the skin. The vein was then cleared 
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and loose ties placed. A catheter of PE 50 polyethylene tubing (I.D . 
. 
. 023"; O.D .. 038") (Clay Adams), previously filled with heparinized 
saline (10 units/ml), was then inserted into the vein towards the heart to a dis-
tance of about 5 em and then withdrawn slightly. Blood was drawn back 
into the catheter to ensure it was in the vein and ties then were 
tightened. The left carotid artery was next exposed and a catheter of 
PE 50 tubing implanted in a similar fashion and clamped with a forceps 
to prevent blood loss. Heparin (0.1 ml of 10,000 units/ml) was injected 
via the jugular venous catheter before the administration of label. 
In the constant infusion experiments, l-14c-glutamine in Krebs-
Henseleit (4-5 ~Ci/ml) was infused via the jugular venous catheter 
using a constant infusion pump (B. Brawn Perfusor, Quigley Rochester Inc., 
Rochester, N.Y.). Following an initial priming dose of 0.7 ml (3-3.5 
~Ci), which was administered in about 5 seconds, the 1-14c glutamine was 
infused at a constant rate of about 1.9 ml/hr for 60-90 min. ~amples 
were taken from the arterial cannula at known times for analysis of 1-14c 
glutamine radioactivity. Samples were also taken at the beginning and 
end of the infusion for the analysis of plasma glutamine levels. The 
withdrawal of samples was timed so that the volume of Krebs-Henseleit-
14c glutamine infused would replace the blood volume taken. Throughout 
the i~fusion, the rectal temperature was monitored using a thermometer 
and the rat was heated by a tungsten lamp. The respiration rate was 
determined throughout and in some experiments, blood pH, pC02 and p0 2 
were determined duri?g the infusion. All measurements assured that the 
animal's condition was stable. (Rectal temr 35-37.5° C, respiration 
.. 
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rate 70-90 breaths/min, pC02 40-50 mm Hg, po2 70-90 mm Hg, pH 7.35-
7. 45). 
The stability of the infusion pump was checked by pumping 14c-
label at a constant setting into scintillation vials containing 15 ml 
Aquasol (New England Nuclear). In one experiment, twenty infusions of 
14 five minutes each were carried out and the C-label pumped averaged 
14,373 + 325 cpm. At the end of each infusion, the pump was calibrated 
by three infusions of two minutes each into scintillation vials con-
taining Aquasol. This enabled the measurement of dpm infused/hr, a 
value that was needed in the calculation of the turnover rate. 
The single injection experiments were carried out using a similar 
technique, although an extremely accurate infusion pump is not necessary. 
l-14c-glutamine label (6.4 ~Ci) was administered as one bolus (0.6 ml) 
into the jugular venous catheter via a Y-connection made using two 23 
gauge needles. This arrangement allowed the continuous infusion of 
Krebs-Henseleit bicarbonate throughout the course of the experiment. 
The infusion of Krebs-Henseleit bicarbonate was carried out at ap-
proximately 3.8 ml/hr and was timed so as to replace fluid lost in the 
withdrawal of blood samples from the arterial cannula. 
B. 14 . 14 Measurement of Specific Radioactivity in 1- C-Glutam1ne and 1- C-
Glutamate 
The accurate measurement of radioactivity in l-14c-glutamine is 
necessary for the measurement of turnover rates. Previously published 
14 . 14 
methods for the determination of radioactivity in C-glutam1ne and C-
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glutamate involved in the use of paper chromatography (14), ion exchange 
chromatography (1) or the use of enzymes which require (a) the adjustment 
of ' pH between steps in the determination and (b) the use of more than one 
sample (20). All of these methods did not appear entirely satisfactory 
and thus a new method was developed which allowed the stepwise deter-
14 
mination of C-label in the plasma bicarbonate, the 1-carbon of glutamic 
acid and the 1-carbon of glutamine on a single plasma sample. 14c-
14 labelled bicarbonate was released as co2 by incubation of the plasma 
sample at pH 5.0. Glutamic acid l-14c-label and glutamine l-14c-label 
were then removed by the successive additions of glutamate decarboxylase 
and glutaminase respectively. The 14co produced in each step was 2 
trapped in center wells containing a strong base. 
Advantages of this method included; (i) there was no necessity for 
the adjustment of pH between samples since both E. coli glutamate de-
carboxylase and~· coli glutaminase were active at pH 5.0, (ii) the 
radioactivity in both l-14c-glutamine and l-14c-glutamic acid was easily 
determined on a single blood plasma sample, (iii) high accuracy is 
obtained since only the actual plasma sample had to be accurately pipetted, 
(iv) determination of radioactivity in plasma 14c-bicarbonate, l-14c-
glutamine and l-14c-glutamic acid could be routinely performed in 2 to 
2 1/2 hours. The principal limitation of the method was the requirement 
of a preparation of glutamate decarboxylase which neither decarboxylates 
substances other than glutamate nor contains glutaminase activity. 
Suitable tests to determine the specificity of the glutamate decarboxylase 
preparation should therefore be made. 
Glutamic acid and glutamine levels in plasma were determined as 
described and used fo~ · the calculation of specific activities. 
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c. Preparation of L-1
14
c-Glutamine 
L-114c-glutamine was prepared using 25 units of glutamine synthetase 
(L-glutamate:ammonia ligase [ADP-forming]; EC 6:3:1:2, Sigma Type III 
from sheep brain) and an incubation mixture of Brosnan and Hall (17). 
The L-114c-glutamine was purified by applying the entire incubation 
mixture (5 ml) to a column containing 29.5 ml Bio-Rad AGl x 8 (50-100 mesh, 
forma te form) as the top layer and 12.5 ml Bio-Rex 70 (50-100 mesh, 
H+ f orm) as the bottom layer (ion exchange resins obtained from Bio-Rad 
Laboratories, Richmond, Cali£ornia). L-114c-glutamine was eluted with 
0 
water , freeze dried, dissolved in isotonic saline, and stored at -20 C 
until used. Recoveries of 14c-label in glutamine averaged 85% using 
this method. Radiochemical purity of the l-14c-glutamine preparation 
was confirmed by application of the method described in the next section 
as well as by a modification of the method of Adam and Simpson (1) as 
described below. 
Two samples of the l-14c-glutamine preparation were used and each 
was taken up in 0.5 ml H2o and added to 0.5 ml of 0.1 M acetate pH 5.0. 
Glutaminase (0.1 international units) was added to tube No. 1 which was 
then incubated for 1 hour at 37° C. At the end of the incubation, 0.1 
ml of 0.5 M sodium phosphate pH 7.0 was added to tube No. 1 to bring the 
pH to 7. Tube No. 2 was not incubated with glutaminase but was adjusted 
to pH 7 with 0.1 ml of 0.5 M sodium phosphate and stored on ice. Samples 
were applied to separate columns (0.7 x 7.0 em) of Bio-Rad AGl x 8 (50-
100 mesh, formate form) and washed successively with 10 ml distilled 
water and 10 ml of 1 M formic acid. Each washing was freeze-dried in 
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scintillation vials, 15 ml Aquasol 2 (New England Nuclear) added, and 
radioactivity determined. Contamination of the l-14c-glutamine with 
neutral compounds was estimated by 
tube No. 1 water wash 
tube No. 2 water wash - tube No. 1 water wash 
while the contamination of the l-14c-glutamine with charged compounds was 
estimated by 
tube No. 2 formic wash 
tube No. 1 formic wash - tube No. 2 formic wash 
Using this method, purities of greater than 95% were obtained for all 
preparations of l-14c-glutamine. 
D. Specificity of the Glutamate Decarboxylase Preparation 
The preparation of glutamate decarboxylase (L-glutamate-l~carboxy-
lyase; EC 4:.1:1:15, Sigma Type V from E. coli) used was reported to have 
a decarboxylase activity with L-glutamine, L-arginine, and L-lysine of 
< 0.1% compared to the activity towards L-glutamate, and a glutaminase 
activity of 0.001%. Using a Gilson Differential Respirometer, the de-
carboxylating activity of the preparation was measured with each of the 
follo~ing groups of amino acids at concentrations of 20 mM in 0.5 M acetate 
buffer, pH 5.0: (i) alanine, glycine, threonine and serine (ii) valine, 
leucine and isoleucine (iii) cysteine and methionine (iv) proline, as-
paragine, and aspartic acid (v) lysine, arginine and histidine (vi) gluta-
mine and (vii) saturated solutions of tyrosine and phenylalanine. No 
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contaminating decarboxylase activity was found since decarboxylation of 
the above groups of amino acids occurred at less than 0.5% of the rate 
obtained using 20 mM glutamate. 
The effect of the glutamate decarboxylase preparation on amino acids 
at the normal plasma levels was also investigated. Fresh arterial 
plasma samples (0.4 ml) were incubated with glutamate decarboxylase (5 
international units) in 2 ml of 0.5 M acetate buffer pH 5.0 for 90 minutes 
0 
at 37 C. At the end of the incubation, 0.6 ml of 12% HC104 was added, 
the mixture was centrifuged and aliquots of the clear supernatant were 
adjusted to pH 2.2 with LiOH. Control samples were treated in a similar 
manner but no glutamate decarboxylase · was added. Amino acid levels in 
bo th control and treated extracts were then measured using an amino acid 
analyzer as described previously. Results showed that all amino acids 
were unaffected by the glutamate decarboxylase treatment except glutamate 
and asparagine. Pure asparagine samples treated in the same manner also 
showed that . the glutamate decarboxylase preparation reacted with asparagine. 
Uniformly labelled L-14c-asparagine (0.5 mM) was carried through the 
as say procedure described below and radioactivity trapped in the center 
wells was counted. Uniformly labelled L-14c-glutamate (0.5 mM) was 
treated in a similar manner for comparison. Results showed that, after 
14 9 0 minutes incubation, one fifth of the radioactivity from C-glutamate 
was recovered while radioactivity in the center wells when 14c-asparagine 
was used was at background levels. From these experiments we were con-
f ident that the glutamate decarboxylase preparation was not contaminated 
with other decarboxylase activities or with glutaminase. 
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Glutaminase (L-glutamine aminohydrolase; EC 3:5:1:2, Sigma Grade V 
from E. coii) was used in the analysis. 
E. Assay Method 
The assay is carried out in 25 m1 Erlenmeyer flasks fitted with 
center wells suspended from rubber stoppers (Kontes Glass Company). 
Center wells contain 0.2 ml of NCS tissue solubilizer (Amersham Searle) 
and filter paper wicks (6). The assay method is outlined in Figure 5. 
Blood samples (400 ~1) were taken from the arterial cannulae directly 
into heparinized micro test tubes and centrifuged at 12,000 x g for 2 
minutes in an Eppendorf micro centrifuge (Brinkman Instruments Inc., 
Toronto, Ontario). A plasma sample (200 ~1) thus obtained was added to 
2. 0 m1 acetate buffer (0.5 M, pH 5.0), the flasks fitted with center 
wells, stoppered, and incubated for 30 minutes at 37° C with shaking. 
Center wells were removed at the end of the incubation and may be counted 
t o determine 14co2 derived from plasma bicarbonate. Glutamic decarboxy-
l ase (5 international units) was then added to the flasks, fresh center 
wells and stoppers fitted, and the flasks incubated again for 30 minutes 
a t 37° C with shaking. Center wells were then counted to determine 
14 1 - C-label in glutamic acid. Glutaminase (0.5 international units) was 
t hen added, fresh center wells and stoppers fitted, and, after a further 
1 hour incubation, center wells were counted to determine l-14c-label in 
glutamine. For determination of radioactivity, the outside of the center 
well was carefully wiped with tissue and the entire center well was then 
added to a scintillation vial containing 10 .11 of Toluene/Omnifluor (New 
14c HCO 
- 3 
14 1- C glu 
14 1- C gln 
GDC 
NCS 
= 
= 
Legend for Figure 5 
14
carbon label in bicarbonate 
14 . 
carbon label in the No. 1 carbon position 
of glutamate 
14
carbon label in the No. 1 carbon position 
of glutamine 
glutamic decarboxylase 
NCS tissue solubilizer 
FIGURE 5 
FLOWCHART FOR THE DETERMINATION OF RADIOACTIVITY IN 
l-14c-GLUT~~TE AND l-14c-GLUTAMINE IN PLASMA SAMPLES 
Blood Sample (0.4 ml) 1 centrifuge 12,000 x g 
Plasma Sample (0.2 ml) 
1 
Add to 2.0 ml acetate buffer 0.5 M, pH 5.0 
center well contains NCS 
incubate 30 min. @37°C 
with shaking 
Remove center well and count radioactivity 
1 
Add 50 ~1 GDC, fresh center well contains NCS 
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incubate 30 min. @ 37°C 
with shaking 
Remove center well and . count radioactivity 14 (=1- C-glu) 
l 
Add 100 ~1 glutaminase, fresh center well contains NCS 
incubate 60 min. @ 37°C 
with shaking 
Remove center well and count radioactivity (=l-14c-gln) 
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England Nuclear). Samples were counted in a refrigerated Beckman LS-233 
liquid scintillation counter. Quench correction was made by the channels 
ratio method; quenching was found to be constant between samples. 
Excellent reproducibility and quantitative recovery of added 
labelled compounds was obtained using this technique. u14c-glutamine 
(New England Nuclear), used in the first series of tests, was initially 
purified by the ion exchange method of Adam and Simpson (1), and added to 
fresh arterial plasma. Samples were then analyzed for l-14c-glutamine 
label by the method just described and values obtained were compared to 
radioactivity measured by pipetting 0.1 ml samples of plasma into 15 ml 
Aquasol 2 in scintillation vials. The results (Table 1) show the ex-
cellent recovery of label as well as excellent reproducibility of the 
assay. Excellent reproducibility was also obtained using plasma samples 
taken from rats that had been infused 1 to 2 hours with l-14c-glutamine. 
14 Results from 10 determinations on a single plasma sample showeq C-
levels of 2449 + 19 (S.D.) cpm/0.2 ml plasma. 
F. Whole Body Analysis 
Whole body analysis for glutamine and other amino acids was per-
formed on normal and acidotic rats in order to measure the size of the 
total _body glutamine pool. This information was hoped to be of some aid in 
the interpretation of the data from the turnover studies. 
Rats, which had had food withheld for four hours, were weighed, 
anaesthesized with i~actin and taped to a cutting board. The rat was 
then quickly sectioned into approximately 30 g pieces with a heavy knife 
... 
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TABLE 1 
Recovery of 14co2 from u
14
c-Glutamine Added to a Fresh 
· Arterial Plasma Sample 
u
14
c-Glutamine Added 
(cpm/0.1 ml plasma) 
143,580 + 5300 (6) 
14
co Recovered* 2 
(cpm/0.1 ml plasma) 
149,160 + 1141 (10) 
% Recovery 
103.9 + 4.0 
Values are repeated as mean + S.D. The number of determinations 
is indicated in parenthesis. 
* These -values were multiplied by 5 since only one-fifth of the 
label in ul4c-glutamine was detected by this assay method. 
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and the pieces immediately frozen in liquid nitrogen in a tared ice 
bucket. Frozen pieces were then selected, wrapped in clean, heavy 
cotton cloth, broken into small fragments with a heavy hammer and re-
turned to the liquid nitrogen. Recovery of tissue, determined by re-
weighing the ice bucket and crushed tissue together, averaged better 
than 95%. Crushed tissue was then homogenized in the cold room in ap-
proximately 1500 ml of 6% HClo4 • A one-gallon waring blender was used, 
and a good homogenate was obtained by 5 x 1 min spins at top speed. 
Recovery from this stage was calculated as the difference in the volume 
of homogenate and the volume of HClo4 used~ Recoveries from all stages 
of the extraction process averaged better than 90%. 
Extracts were next prepared for complete amino acid analysis. The 
homogenate was filtered through 4 layers of cheesecloth and centrifuged 
in an Eppendorf microfuge (12,000 x g for 2 min). Clear extracts were 
then adjusted to pH 2.2 and amino acid analysis performed as de?cribed. 
IV. PRESENTATION AND ANALYSIS OF DATA 
Data werereported as mean+ S.D. (standard deviation) with the 
sample size (n) in parenthesis. Differences between populations were 
tested for statistical significance by t-test. Arterial and venous 
samples were obtained from the same rat when possib~e. A paired t-test 
was used for the~data. P values of 0.05 or less were taken to indicate 
a significant difference between populations . 
., ·- . 
-
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RESULTS 
I. AMINO ACID METABOLISM BY THE KIDNEY 
A. Whole Blood and Plasma Amino Acid Levels 
Amino acid levels in whole blood and plasma obtained from normal 
and acidotic rats were measured to determine if differences exist. Re-
sults are reported in Table 2 and illustrated in Figure 6. In these 
experiments, whole blood and plasma samples were taken from the same 
rats and the data obtained are thus paired. 
Levels of glycine, glutamic acid, lysine and arginine were lower in 
plasma than in whole blood in both normal and acidotic rats. These 
amino acids therefore must be concentrated within the blood cells.* 
Further, this concentration gradient is independent of acid-base status 
of the rat. Changes in both whole blood and plasma amino acid levels 
occur in acidosis. Levels of serine, threonine and lysine were higher 
and levels of glutamine were lower in both whole blood and plas~a during 
acidosis. As a result, the total free amino acid level in blood was in-
creased in acidosis. 
B. Arterio-Venous Differences Across the Kidney for All Amino Acids 
Measurements of arterio-venous differences must be made using whole 
blood ·to take into account the possible involvement of red blood cells in 
the transport of metabolites. Arterio-renal venous differences for 
nineteen amino acids using whole blood are reported in Table 3 and il-
lustrated in Figure 7. These measurements were made so as to quantitate 
the net metabolism of the various amino acids by the normal and acidotic 
* In subsequent discussion, where "erythrocytes" or "red blood cells" have 
been mentioned, it should read "blood cells", since our experiments do not 
distinguish between the different types of. blood cells. 
TABLE 2 
Amino Aci d Levels i n Arteri al Whole Blood and Plasma from Normal and Acidotic Rats 
Results are expressed as llmoles/ml of whole blpod or of plasma + S.D. n = 4 in all cases. BLD represents Below 
Limits of Detection. 
NORMAL ACIDOTIC 
Blood Plasma P Blood Blood Plasma P Blood P Acidotic 
Levels Levels Different Levels Levels Different Blood Dif-
from Plasma from Plasma ferent from 
Normal Blood 
Glycine 0.28 + 0.05 0.18 + 0.02 <0.025 0.33 + 0.07 0.21 + 0.01 <0.05 NS 
Alanine 0.36 + 0.08 0.42 + 0.06 NS 0.44 + 0.06 0.47 + 0.06 NS NS 
Serine 0.21 + 0.03 0.20 + 0.03 NS 0.28 + 0.03 0.27 + 0.03 NS <0.001 
Threonine 0.25 + 0.02 0.26 + 0.02 NS 0.39 + 0.01 0.43 + 0.11 NS <0.001 
Leucine 0.12 + 0.01 0.13 + 0.20 NS 0.11 + 0.01 0.12 + 0.01 NS NS 
Isoleucine 0.08 + 0.01 0.09 + 0.01 NS 0.07 + 0.01 0.08 + 0.01 NS NS 
Valine 0.16 + 0.01 0.18 + 0.02 NS 0.14 + 0.01 0.15 + 0.01 NS NS 
Proline 0.20 + 0.03 0.19 + 0.02 NS 0.26 + 0.06 0.22 + 0.02 NS NS 
Tyrosine 0.07 + 0.02 0.08 + 0.01 NS 0.08 + 0.01 0.09 + 0.01 NS NS 
Phenylalanine 0.05 + 0.01 0.05 + 0.01 NS 0.05 + 0.01 0.06 + 0.01 NS NS 
Methionine BLD 0.04 + 0.01 BLD 0.06 + 0.00 
Aspartic Acid 0.03 + 0.01 BLD 0.02 + 0.01 BLD 
Glutamic Acid 0.20 + 0.01 0.11 + 0.02 <0.001 0.17 + 0.02 0.10 + 0.02 <0.010 NS 
Asparagine 0.06 + 0.01 0.05 + 0.01 NS 0.08 + 0.01 0.06 + 0.01 NS NS 
Glutamine 0.54 + 0.04 0.59 + 0.09 NS 0.38 + 0.04 0.41 + 0.02 NS <0.005 
Lysine 0.51 + 0.05 0.39 + 0.05 <0.05 0.77 + 0.04 0.62 + 0.03 <0.005 <0.001 
Ornith ine 0.06 + 0.01 0.07 + 0.00 NS 0.07 + 0.01 0.05 + 0.00 NS NS 
Histidine 0.06 + 0.01 0.07 + 0.00 NS 0.07 + 0.00 0.08 + 0.00 NS NS 
Arg i nine 0.29 + 0.04 0.20 + 0.04 <0.05 0.34 + 0.04 0.21 + 0.07 <0.050 NS 
V1 
\0 
Arterial Blood and Plasma Amino Acid Levels 
in Normal Rats 
• <' p 
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FIG. 6. Arterial Blood and Plasma Amino Acid Levels in Normal Rats. 
TABLE 3 
Arterial Amino Acid Levels and Arterio-Renal Venous (A-V) Differences in Normal and Acidotic Rats 
Results are expressed as ~moles/ml blood + S.D. n = 6, except where noted. A positive difference implies 
an uptake by the kidney. 
Amino Acid Arterial 
Glycine 0.39 + 0.13 
Alanine 0.46 + 0.15 
Serine 0.20 + 0.05 
Threonine 0.25 + 0.05 
Leucine 0.12 + 0.02 
Isoleucine 0.07 + 0.01 
Valine 0.17 + 0.03 
Proline 0.22 + 0.09 
Tyrosine 0.08 + 0.02 
Phenylalanine 0.05 + 0.01 
Methionine 0.30 + 0.01 
Aspartic Acid 0.04 + 0.02 
Glutamic Acid 0.29 + 0.07 
Asparagine + 
Glutamine 0.48 + 0.08 
Lysine 0.45 + 0.10 
Ornithine 0.06 + 0.02 
Histidine 0.05 + 0.00 
Arginine 0.23 + 0.04 
NORMAL ACIDOTIC 
A-V 
+0.05 + 0.13 
0.00 + 0.08 
-0.06 + 0.03 
-0.03 + 0.04 
-0.01 + 0.02 
-0.01 + 0.01 
-0.02 + 0.03 
+0.02 + 0.06 
-0.01 + 0.01 
0.00 + 0.01 
-0.01 + 0.05 
-0.01 + 0.02 
0.00 + 0.09 
+0.03 + 0.05 
+0.00 + 0.04 
0.00 + 0.01 
-0.01 + 0.00 
-0.02 + 0.01 
(5) 
P Value 
A-V Different 
from Zero 
NS 
NS 
<.025 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
<.005 
<.05 
Arterial A-V 
0.47 + 0.08 +0.04 + 0.06 
0.46 + 0.03 +0.01 + 0.02 
0.33 + 0.07 -0.05 + 0.02 
0.43 + 0.08 -0.01 + 0.01 
0.11 + 0.02 0.00 + 0.01 
0.06 + 0.02 0.00 + 0.01 
0.16 + 0.03 0.00 + 0.01 
0.22 + 0.04 -0.01 + 0.02 
0.10 + 0.02 -0.01 + 0.01 
0.05 + 0.01 -0.01 + 0.01 
0.02 + 0.01 -0.01 + 0.01 
0.02 + 0.02 -0.01 + 0.02 
0.20 + 0.05 -0.02 + 0.05 
0.36 + 0.05 +0.11 + 0.05 
0.62 + 0.08 +0.04 + 0.13 
0.05 + 0.01 0.00 + 0.01 
0.06 + 0.01 +0.01 + 0.01 
0.32 + 0.05 +0.01 + 0.07. 
(4) 
(5) 
(5) 
(4) 
(5) 
P Value 
A-V Different 
from Zero 
NS 
NS 
<.005 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
<.005 
NS 
NS 
NS 
NS 
"' 1-' 
p 
Amino 
Acid 
. GLY 
ALA 
SER 
THR 
LEU 
-0.2 
I 
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Arterio-Venous Differences for A:mmo Acids Across 
Kidneys of Normal and Acidotic Rats 
}J moles/ml 
-0.1 0 
I 
+ 0.1.· 
I 
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·+0.2 
I 
.-0.2 
I 
p moles/ml 
-0.1 0 
' 
. I 
.. \ 
+0.1 
I 
0.005 
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FIG. 7. Arterio-Venous Differences for Amino Acids Across Kidneys of Normal 
and Acidotic R~!: .s. 
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rat kidneys. In these experiments, arterial and venous samples were 
taken from the same rat and, as a consequence, paired statistics were 
applied to the data. 
The results show significant outputs of serine by both the normal 
and acidotic kidney, as well as small but significant outputs of 
histidine and arginine by the normal kidney. No amino acids were taken 
up in significant amounts by the normal kidney. However, the glutamine 
+ asparagine fraction was decreased after passage through the kidney 
during acidosis. However, experiments reported in Table 4 show that 
asparagine, which is present at low concentrations in blood, is not re-
moved by the acidotic kidney. Thus, it is glutamine alone that is re-
moved by the acidotic kidney to such a large extent. Measurements of 
urinary amino acid levels (72) showed that the small amount of glutamine 
appearing in the urine could in no way account for the glutamine removed 
from the blood by the kidney. 
C. Whole Blood and Plasma Kidney Arterio-Venous Differences 
Since glutamine was removed from the arterial blood by the acidotic 
kidney, arteria-renal venous differences were measured using both whole 
blood and plasma to determine the extent of glutamine and glutamate uptake 
from the blood cells and plasma (Table 4). Plasma glutamine arterio-venous 
differences were greater than whole blood glutamine arterio-venous differences 
(P < .005). Haematocrits were measured for normal and acidotic arterial blood 
and found to be 43.6 + 2.4 (4) and 43.7 + 3.9 (6) respectively. Thus since 
plasma occupies 56.3% of the blood volume of acidotic rats, we may cal-
TABLE 4 
Plasma and Whole Blood Levels and Arterio-Venous Differences for 
Glutamine, Glutamate and Asparagine Across Kidneys of Acidotic 
Rats 
Results are expressed as vmoles/ml + S.D. n 5 in all cases. 
Blood Plasma 
Glutamine Renal Vein 0.37 + 0.07 0.33 + 0.11 
Artery 0.46 + 0.03 0.50 + 0.08 
A-V 0.10 + 0.05 0.17 + 0.07 
p for A-V 
Different 
from Zero <0.025 <0.005 
Glutamate Renal Vein 0.15 + 0.01 0.06 + 0.02 
Artery 0.14 + 0.02 0.08 + 0.02 
A-V 0.03 + 0.01 
P for A-V 
Different 
from Zero NS <0.005 
Asparagine Renal Vein 0.05 + 0.01 0.05 + 0.01 
Artery 0.05 + 0.01 0.05 + 0.01 
A-V 
p for A..:...v 
Different 
from Zero NS NS 
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culate that for every millilitre of blood that perfuses these kidneys 
in vivo 0.096JUmole of glutamine (0.533 x 0.170) (kidney arterio-venous 
difference for plasma glutamine is 0.170J1mole/ml, Table 4) is, on the 
average, extracted from the plasma. Similarly, for every millilitre 
of blood that perfuses these kidneys in vivo a total of 0.095JUmole of 
glutamine (1 x 0.095) (kidney arterio-venous difference for blood 
glutamine is 0.095 pmole/ml, Table 4) is extracted from the blood. This 
remarkable agreement in values indicates that glutamine taken up by the 
acidotic kidney is removed predominantly from the plasma and that the 
erythrocyte glutamine levels remain unchanged as the blood passes 
through the kidney. In contrast, while the whole blood arterio-venous 
difference for glutamate showed no uptake of glutamate by the kidney, 
arterial plasma levels were significantly elevated above the renal venous 
plasma levels. Thus, glutamate moyes from the plasma into the erythro-
cytes as the blood perfuses the kidney. There was no significant change 
in the conc~ntration of asparagine in whole blood or plasma after passage 
through the kidney. 
D. Metabolism of Lactate by the Kidney 
In a further study of kidney metabolism, arterio-venous differences 
for lactate were measured across the normal and acidotic rat kidney. 
This study was undertaken to determine whether lactate, which is an 
important fuel of the normal kidney, is replaced by glutamine, 
in the acidotic kidney. Since in the dog total co2 production does not 
differ in acidosis (46) one might expect that if glutamine carbon is 
oxidized to co2 in the acidotic rat kidney, the uptake and oxidation of 
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lactate for energy production may be reduced. Results reported in Table 
5, however, show that kidneys from both normal and acidotic rats removed 
comparable quantities of lactate from the blood. In addition, there was 
no significant difference in arterial lactate concentrations between 
normal and acidotic rats. 
II. GLUTAMINE METABOLISM IN THE WHOLE RAT 
The remainder of the experiments performed deal with measurements 
of the overall metabolism of glutamine in the entire rat. Experiments 
were performed in the hope of detecting the changes which occur in over-
all glutamine metabolism in acidosis. 
A. Measurement of the Turnover Rate of Glutamine 
The first series of experiments involved the measurement in vivo of 
the turnover rate of plasma glutamine in normal and acidotic rats. Since 
Table 3 unequivocably demonstrated increased renal glutamine extraction 
in the rat it was felt that turnover studies would give information on 
the "source" of this glutamine. Thus, if extra glutamine were synthesized 
during acidosis one should see an increased glutamine turnover. However, 
if the renal glutamine were provided via a decreased glutamine utilization 
by other tissues, then there should be no change in glutamine turnover. 
As outlined in the Introduction, two different techniques were used in 
the measurement of turnover rates, namely single injection and constant 
infusion. 
TABLE 5 
Arterial Blood Lactate Concentrations and Renal Arterio-Venous Differences 
of Lactate in Normal and Acidotic Rats 
Results are expressed as ~moles/ml + S.D. 
Arterial 
A-V Difference 
P for A-V Different 
from Zero 
Normal (6) 
1. 65 + 0.46 
+0.31 + 0.08 
<0.001 
Acidotic (9) 
1.63 + 0.38 
+0.32 + 0.22 
<0.005 
P (normal different 
from acidotic) 
NS 
NS 
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A typical set of results obtained from a single injection experi-
ment is plotted in Figure 3 (page 33). After an initial rapidly changing 
r ate of decline in log 10 of plasma glutamine specific activity, a linear 
r ate of decrease with time was obtained. As previously discussed in 
the Introduction, the slope of the linear portion of the plot as well as 
the y-intercept are used in the calculation of turnover rate and pool 
size. 
A typical set of results obtained by using the constant infusion 
technique is plotted in Figure 8. Note that a plateau was quickly es-
tablished in plasma glutamine specific activity, indicating that the 
label has eq'uilibrated throughout the pool to a constant specific ac-
tivity. From the position of this plateau as well as the rate of in-
fusion of label, the turnover rate can be calculated. 
The turnover rates of 1-14c glutamine in normal and acidotic rats 
measured by both techniques are reported in Table 6. There was no 
difference in turnover rates of glutamine between normal and acidotic 
rats as measured by both methods. However, rates measured by single 
injection were more than twice those measured by the constant infusion 
technique. 
Values for the pool size of glutamine calculated from the single 
injection experiments also appear in Table 6. Similar values were ob-
ta ined for normal and acidotic rats. Experiments were now performed to 
determine how closely the calculated pool size approximates the total 
body glutamine pool. In addition, differences in whole body levels of 
various amino acids were measured between normal and acidotic rats. 
··  .. 
Legend for Figure 8 
Shown bere is a typical plot of the data obtained by the constant in-
fusion technique. In this particular experiment an acidotic rat was 
used (wt = 332 g). 1-14c glutamine (8.16 x 106 cpm/ml) was infused at 
a rate of 1.54 x 107 cpm/hr. 
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FIG. 8. Constant Infusion Method fo.r the Measurement of Glutamine Turnover. 
TABLE 6 
· Turnover Rates of l-14c-Glutamine in Normal and Acidotic Rats 
Normal 
Acidotic 
P (normal different 
from acidotic) 
Single Injection 
282.4 + 32.6 (4) 
308.8 + 35.5 (5) 
NS 
Constant Infusion 
133.8 + 8.4 (5) 
131.2+27.4 (5) 
NS 
Pool Size (from 
single injection studies 
(umoles/100 g) 
130.6 + 31.6 
120.2 + 15.5 
NS 
Values for turnover rates are in umoles/hr/100 g body wt. Numbers in parenthesis refer to the 
number of experiments performed in each group. 
,· 
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B. Measurement of Whole Body Amino Acid Levels 
Whole body extracts were prepared as described in the methods sec-
tion and the concentrations of amino acids are reported in Table 7 and 
illustrated in Figure 9. Whole body glutamine levels are approximately 
twice as high as the pool size calculated from the single injection 
studies. It thus seems that plasma glutamine does not freely 
equilibrate with all tissues. The turnover rates reported are thus for 
a glutamine pool which comprises only one-half of the total body gluta-
mine. The actual tissues which comprise this pool are not known. 
Differences were detecte~ in whole body levels of some amino acids 
between normal and acidotic rats. Whole body levels of two hydroxy-amino 
acids, serine and threonine as well as three basic amino acids, lysine, 
histidine and arginine, as well as citrulline were higher in acidotic 
than normal rats. However, on ly the increased levels of serine, 
threonine, and lysine were re£lected in increased blood levels of these 
amino acids during acidosis. 
Other workers have measur ed glutamine levels in various tissues 
which have been rapidly freez e -clamped after removal from the animal. 
Glutamine levels measured by ~his technique may therefore more closely 
approximate actual levels in v ivo. It is of interest therefore to 
estimate the whole body pool of glutamine by a summation of these data. 
Despite the considerable assumptions in the calculation it is remarkable 
that the calculated whole body glutamine (Table 8) agrees so well with 
the experimentally determined value (Table 7). 
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TABLE 7 
Con~entrations of Amino Acids and Other Ninhydrin Positive Substances in 
Whole Body Extracts of Normal and Acidotic Rats 
Results are expressed as ~moles/100 g body wt + S.D. n = 4 except where 
indicated. 
Normal Acidotic p (Acidotic different 
from Normal) 
Glycine 305.7 + 36.6 318.3 + 24.3 NS 
Alanine 146.9 + 2.7 146.8 + 7.7 NS 
Serine 105.2 + 7.8 142.6 + 8.0 <.005 
Threonine 65.3 + 6.4 95.9 + 5.7 <.001 
Leucine 15.1 + 2.7 13.5 + 2.1 NS 
Isoleucine 11.1 + 2.7 10.3 + 1.8 NS 
Valine 15.2 + 5.1 16.3 + 3.7 NS 
Proline 26.0 + 3.2 31.0 + 2.0 NS 
Tyrosine 12.8 + 2.9 15.3 + 1.8 NS 
Phenylalanine 7.1 + 1.2 7.2 + 0.5 NS 
Methionine 6.5 + 1.5 7.8 + 0.6 NS 
Glutamic Acid 188.0 + 10.9 174.8 + 9.3 NS 
Asparagine 13.1 + 2.0 13.7 + 1.4 NS 
Glutamine 263.8 + 11.5 243.9 + 26.6 NS 
Lysine 57.4 + 13.2 117.9 + 12.6 <.005 
Ornithine 6. 7 + 2.0 7.0 + 1.4 NS 
Histidine 23.0 + 3.7 31.5 + 1.5 <.025 
Arginine 56.5 + 5.6 95.9 + 10.6 <.005 
Hydroxyproline 11.4 + 5.7 8.5 + 1.4 (3) NS 
Taurine 997.7 + 78.0 (3) 958.5 + 25.9 NS 
Citrulline 10.6 + 1.2 14.3 + 1.3 <.025 
Carnosine 164.0 + 39.6 151.0 + 8.6 NS 
Anserine 257.6 + 63.2 246.4 + 17.7 NS 
Amino Acid 
GLY 
ALA 
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THR 
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TABLE 8 
Glutamine Levels in Various Tissues of the Rat 
Tissue Ref Percentage of Ave Gln Cont ent Ave Gln Content 
~oles/g tissue) Body wt (g%) (1) (umoles/100 g body 
Huscle 3.3 3 41.7 137.6 
Skin 2.0 * 18.0 36.0 
Blood 0.57 5 8.0 4.6 
Liver 2.68 4 2.3 6.2 
Brain 4.51 5 2.0 9.0 
Intestine 0.55 3 1.8 1.0 
Lungs 1.12 4 0.7 0.8 
Heart 5.99 4 0.5 3.0 
Kidney 1. 72 2 0.4 0.7 
Spleen 1.27 4 0.2 0.3 
Adipose Tissue * 0-10 0 
Skeleton * 15.9 0 
Total Gln Content 199.1 
* Estimated values. 
1. Pitts, R.F. "Physiology of the Kidney and Body Fluids", 3rd ed, pll, Year Book 
Medical Publishers, Chicago, a974h (Values for a 70 kg man). 
2. Brosnan, J.T. D.Phil thesis. Oxford University (1968). 
3. Windmueller, H.G. and Spaeth, A.E. J. Biol. Chern. 249; 5070-5079 (1974). 
4. Herbert, J.D., Coulson, R.A. and Hernandez, T. Comp. Biochem. Physiol. ll• 
583-598 (1966). 
wt ) 
5. Lund, P. In "Methods of Enzymatic Analysis", 2nd ed, vol. 4, Ed. H.U. Bergmeyer, 
pl719-1722, Academic Press (1974). 
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C. Arterio-Venous Differences for Glutamine and Glutamate Across all Organs 
The final set of experiments involve the direct measurement of · 
arterio-venous differences across various organs in the intact rat. 
These were performed in an attempt to obtain direct information on the 
sites of glutamine utilization and provision in the rat. Since, in 
these experiments blood samples from the various veins and the arteries 
were obtained from the same rats, the data obtained were paired and 
paired statistics were therefore applied. 
The data for glutamine arterio-venous differences are reported in 
Table 9 and illustrated in Figure 10. In the normal rat, glutamine is 
produced by the muscle (A-FV difference). No significant uptake of 
glutamine by any tissue was observed. Experiments performed by other 
investigators have, however, showed that the intestine normally removes 
glutamine from the blood (82). In addition, previous work (72) yielded 
unpaired data which showed an uptake of glutamine by the G.I.T. of the 
normal rat .. Apparently the larger random errors in thesedata have masked 
any significant arterio-venous difference across the G.I.T. which may be 
obtained. In acidosis, the kidney removes approximately 40% of the total 
arterial glutamine in each pass through the kidney. The intestinal bed 
also removes glutamine, but the A-PV difference is much less than the 
A-RV difference. The site of glutamine production in the acidotic rat is 
not apparent from these data. The muscle may produce glutamine in acidosis 
as well as in normal acid-base status. However, there did not seem to be 
increased glutamine production by muscle during acidosis, although the 
variability in the data was rather large. 
Jugular Vein 
Femoral Vein 
Portal Vein 
Renal Vein 
Hepatic Vein 
Arterial 
TABLE 9 
Whole Blood Glutamine Levels and Arterio-Venous Differences Across 
Various Tissues of the Rat 
Normal Acidotic 
Blood Levels A-V p (Vein Different Blood Levels A-V 
from Artery) 
0.420 + .050 -0.026 + .045 NS 0.323 + .086 -0.009 + .056 
0.455 + .059 -0.061 + .016 <.001 0.342 + .115 -0.028 + .099 
0.357 + .050 0.038 + .042 NS 0.287 + .065 0.027 + .020 
0.397 + .048 -0.003 + .053 NS 0.184 + .064 0.130 + .054 
0.387 + .069 0.008 + .049 NS 0.287 + .044 0.027 + .046 
0.395 + .054 0.314 + .070 
n = 6 in all cases, values are expressed in pmoles/ml blood. 
p (Vein Different 
from Artery) 
NS 
NS 
<.025 
<.001 
NS 
Vein 
Sampled 
JUGULAR 
FEMORAL 
PORTAL 
RENAL 
HEPATIC 
ARTERIAL 
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Whole Blood Glutamine Levels tn Blood Vessels 
of the Rat 
.p 
( Vein different 
..umoles 1 ml from artery) 
0 .2 .3 .4 .6 
I 
NS 
NS 
·· .. (.001 
N s· 
NS 
(.025 
NS 
(.001 
NS 
NS 
~=-Normal L--...j' ~ Acidotic 
FIG. 10. Whole Blood Glutamine Levels in Blood Vessels of the Rat. 
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Arterio-venous differences for glutamate were also measured on 
these same rats. Since glutamate is a precursor of glutamine, it was 
of interest to determine if glutamine production and glutamate uptake 
were closely related. Results are reported in Table 10 and illustrated 
in Figure 11, and show, however, no uptake of glutamate by glutamine 
producing tissues. In fact, the muscle and brain of the normal rat re-
lease glutamate. The G.I.T. also releases glutamate;however this 
release was only found to be significant during acidosis. Glutamate 
released by the G.I.T. may be derived from the metabolism of glutamine. 
Jugular Vein 
Femoral Vein 
Portal Vein 
Renal Vein 
Hepatic Vein 
Arterial 
TABLE 10 
Whole Blood Glutamate Levels and Arterio-Venous Differences Across 
Various Tissues of the Rat 
Normal Acidotic 
Blood Level A-V p Blood Level A-V 
0.176 + .010 -0.024. + .019 <.05 0.128 + .026 -0.002 + .031 
0.163 + .013 -0.011 + .011 <.05 0.120 + .040 0.007 + .049 
0.170 + .018 -0.018 + .022 NS 0.145 + .021 -0.018 + .016 
0.147 + .017 0.005 + .024 NS 0.132 + .051 -0.005 + .023 
0.169 + .032 -0.017 + .035 NS 0.138 + .022 -0.012 + .021 
0.152 + .018 0.126 + .034 
n = 6 in all cases, values are expressed in umoles/ml blood. 
p 
NS 
NS 
<.05 
NS 
NS 
Vein 
Sampled 
JUGULAR 
FEMORAL 
PORTAL 
RENAL 
HEPATIC 
·. 
Whole Blood Glutamate 
of the 
)Jmoles 1 ml 
Levels 
Rat 
.3 -
I 
ARTERIAL 
tn Blood 
r 
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Vessels 
p 
( Vein different 
from artery ) 
(.05 
NS 
<.05 
NS 
NS 
<.05 
NS 
NS 
NS 
NS 
~=-Normal L--_ __.l:z Acidotic 
FIG. 11. Whole Blood Glutamate Levels in Blood Vessels of the Rat. 
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DISCUSSION 
I. AMINO ACID METABOLISM BY THE KIDNEY 
A. Whole Blood and Plasma Amino Acid Levels 
The measurements of amino acid concentrations in plasma and in whole 
blood demonstrated consistently lower levels of glycine, glutamate, 
lysine and arginine in plasma than in whole blood. Such uneven dis-
tributions of amino acids across the erythrocyte membrane have pre-
viously been reported in blood from dogs (26, 28) and man (7, 8, 30). 
Although the mechanisms by which these uneven distributions are main-
tained are uncertain, it is clear that passive distribution in response 
to Gibbs-Donnan effects is not solely responsible. This inference is 
based on the observation that a neutral amino acid . (glycine) , an 
acidic amino acid (glutamic acid) and two basic amino acids (lysine and 
arginine) are all concentrated inside the erythrocytes. 
Differences were also found in the levels of some amino acids in 
whole blood and plasma in acidosis. The increased levels of serine, 
threonine, and lysine observed in both whole blood and plasma of the 
acidotic rat are reflected in increased whole body levels of these 
amino acids. Hm-1ever, although no change in the total free glutamine 
content of rat was observed during acidosis, significantly lower whole 
blood and plasma glutamine levels were observed in the acidotic rat. 
Although this decrease has not been observed previously by some in-
vestigators (51, 81), others have found significantly decreased levels 
of glutamine in acidotic sheep (35) and man (56). It may be that the 
decrease in circulating glutamine levels is Jue to the increased renal 
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utilization of this amino acid during acidosis. This has been borne out 
by a recent observation (58) that as renal extraction of glutamine in-
creases during the onset of acidosis the blood glutamine level falls 
and as renal extraction of glutamine declines during recovery from 
acidosis the blood glutamine level returns to normal. The lower levels 
of glutamine during acidosis may signal a lessening of glutamine 
utilization by extrarenal tissues. 
B. Arterio-Venous Differences Across the Kidney 
Arterio-venous differences for all amino acids across the kidney 
show significant outputs of serine by both the normal and acidotic kidney 
as well as small but significant outputs of histidine and arginine by 
the normal kidney. Renal output of serine has been observed in acidotic 
and alkalotic dogs (71), in normal and acidotic man (56) and in normal 
and starved rats (4, 86). That such renal serine production is seen in 
acidosis and in alkalosis as well as in fed and starved animals indicates 
that its production is related neither to the acid-base status of the 
animal nor to the provision of gluconeogenic amino acids. The precursor 
of this serine is thought to be glycine (60), although in our studies 
the arterio-venous difference for glycine uptake across the kidney was 
not statistically significant. 
There was no production of alanine by either the normal or acidotic 
kidney. Renal alanine output has been found in dogs (61, 71), rats (4, 
86) and man (56). However, the output in the rat was quite modest, and 
some workers (18) have reported a small upta~-.e of alanine by the human 
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kidney. Thus it appears that alanine release is not an inevitable re-
sult of renal metabolism. 
The only amino acid extracted by the kidney was glutamine, which 
was removed in significant quantities only during acidosis. It has been 
reported that rat kidney slices (22) and the perfused rat kidney (59) 
produce ammonia from amino acids other than glutamine. Such ammonia 
production has also been shown to be more rapid in slices and in per-
fused kidneys from acidotic rats. However, from our measurements in vivo 
it is apparent that glutamine is the major source of urinary ammonia in 
the acidotic rat. It is probable that both nitrogens of glutamine are 
employed for ammonia production, since no increase in amino acid release 
by the kidney occurs during acidosis. 
C. Permeability of Erythrocytes to Glutamine and Glutamate 
The measurement of glutamine arterio-renal venous differences using 
both whole blood and plasma have indicated that glutamine is removed by 
the kidney only from the plasma. The very slow movement of glutamine 
across the erythrocyte membrane is undoubtedly the cause of the non-
involvement of the erythrocyte glutamine pool in ammonia production. 
Measurements in vitro showed that labelled glutamine penetrated the cell 
membrane extremely slowly and, in addition, the erythrocyte glutamine 
pool was extremely resistant to depletion by washing (data not shown). 
Preliminary measurements of the rate of equilibration of labelled 
glutamine between blood cells and plasma in vivo were inconclusive and 
proved technically unfeasible due to the fast removal of the label from 
the blood. However, a slow equilibration between erythrocyte and plasma 
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glutamine must occur in vivo since the large decrease in blood glutamine 
during acidosis is equally manifest in plasma and in whole blood. Pitts 
I 
et al. (61, 63) have also demonstrated in the dog that the kidney removes 
glutamine primarily from plasma. 
Measurements in vitro have also shown that labelled glutamate fails 
to ~uickly penetrate the erythrocyte membrane and that intracellular 
glutamate is very resistant to depletion by washing (data not shown). 
However, in contrast to the in vivo data obtained with glutamine, there 
appears to be a rapid movement of glutamate between the erythrocytes and 
plasma in vivo. Thus, although there was no significant uptake or out-
put of glutamate by the acidotic kidney, the concentration of glutamate 
in the arterial plasma was significantly higher than in the renal venous 
plasma. Hence, a movement of glutamate from plasma to erythrocytes 
occurred as the blood passed through the kidney. A movement of glutamate 
into erythrocytes has previously been reported by Aoki ~ al. \8) and 
Elwyn (26, 28). It is possible that during passage of the blood cells 
through narrow capillaries, the transport of amino acids may be 
facilitated in some manner through contact with the capillary walls. It 
has been suggested (8) that insulin may affect the uptake and release of 
glutamate by the red blood cells. 
D. Renal Lactate Metabolism 
The induction of acidosis had no effect on either the arterial 
lactate levels or the renal extraction of lactate. Other authors (88) 
have reported that, in the acutely acidotic rat, no change in renal 
.. :. . 
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lactate oxidation has been observed in vitro. In contrast, Leal-Pinto 
et al. (46) reported decreased lactate uptake by the acidotic dog kidney 
compared to the alkalotic dog kidney. In addition, no difference in 
co2 production by the kidney was measured in these two acid-base states. 
However, since no measurement of lactate extraction by the normal dog 
kidney was made by these authors, it is not possible to say whether more 
or less lactate is used by the normal dog kidney. Thus, it appears likely 
that in the acidotic rat kidney glutamine does not replace lactate as a 
major fuel of respiration. However, the acidotic dog kidney appears to 
utilize less lactate, presumably due to increased oxidation of glutamine 
carbon to co2 • 
II. MEASUREMENTS OF THE OVERALL METABOLISM OF GLUTAMINE 
A. Measurement of Turnover Rates 
The measurement of the turnover rate of l-14c-glutamine in the rat 
has involved considerable effort. 14c-glutamine specifically labelled 
in the 1-carbon position is not available commercially and I therefore 
synthesized and purified this compound. Glutamine synthetase (Sigma 
Type III from sheep brain) was used with the incubation mixture of 
Brosnan and Hall (17) and the l-14c-glutamine synthesized was made 
virtually salt-free and pure by the use of ion exchange resins as de-
scribed in the methods section. It was also necessary to develop a good 
method for the measurement of the specific activity of the l-14c~glutamine 
in the blood, since methods available in the literature were not entirely 
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satisfactory. A completely new and precise method was thus developed 
using the sequential action of glutamate decarboxylase and glutaminase. 
Methods were also developed to confirm the purity of the commercial 
glutamate decarboxylase preparation. 
The measurement of the turnover rates of glutamine in the normal and 
acidotic rat should give valuable insight into the changes which occur 
in glutamine metabolism during acidosis. The increased renal extraction 
of glutamine during acidosis (Table 3) demands increased amounts of 
glutamine to be available to the kidney. This may be accomplished by 
either increased glutamine production by whatever tissues produce 
glutamine or decreased glutamine utilization by extrarenal tissues such 
as the G.I.T. If more glutamine was synthesized during acidosis, an 
increased rate of overall turnover of glutamine would be expected. 
However, if a compensatory decrease in utilization of glutamine by ex-
trarenal tissues were to occur in response to increased renal extraction 
of glutamine, no change in the turnover rate of glutamine would be ex-
pected. Since no change in the turnover rate of glutamine was noted by 
either method, it appears that glutamine production does not increase in 
acidosis. 
(i) Differences between Single Injection and Constant Infusion 
Values. 
Of interest is the large discrepancy in the value of the turnover 
rate of glutamine as measured by the two different methods. The turnover 
rate as measured by . the single injection technique was always substantially 
greater than that measured using the constant infusion method. A similar 
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but substantially smaller discrepancy in the values obtained for the 
turnover rate of glucose has been reported (37). These authors have 
reviewed the extensive work done to resolve this problem. The discrepancy 
comes, according to these authors, from the simple interpretation applied 
to the single injection data. Thus, the Zilversmit formula discussed 
earlier in the Introduction utilizes only the monoexponential portion of 
the ln glutamine specific activity versus time curve and assumes a simple 
two-compartment model. 
One can rewrite the Zilversmit formula given previously: 
where b* mass of injected l-14c-glutamine 
B mass of glutamine in the pool (i.e., pool size) 
= turnover rate 
db* 
-Vl dt b B 
in the form given by Hetenyi and Norwich (37): 
db* -V 1 b* 
--dt B 
Solving the equation they get: 
-Vl ln bo * ln b* t + 
--
B B B 
where b is the specific activity of glutamine at t 0. 
0 
This equation may be expressed in exponential form: 
b*t b 0 * ( 
-v .. ) 
exp B 1 t/ 
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Upon integration of the b* versus time curve between the time of zero and 
infinity, the total area is given by: 
Area 
The turnover rate can now be obtained from: 
b * B 0 
Area 
Dividing the numerator and denominator by the pool size B: 
b * 0 I-; dt 
0 
where b is the specific activity of glutamine in the pool at any time. 
It is apparent that if only the area under the monoexponential part 
of the specific activity decay curve is utilized rather than the entire 
area, the denominator in the equation above would be too small making the 
calculated v1 value too large. Thus, all processes which act to remove 
or disperse label from the point where it enters the system should be 
considered if one is to obtain the same values as that obtained by the 
constant infusion method. In the latter, such processes which occur at 
multiexponential rates are inherently measured since these processes act 
continuously on all new label infused into the system. 
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The reason for the large discrepancy in the values obtained for 
glutamine turnover compared to the relatively minor discrepancies found 
in values for glucose turnover may also be apparent. Processes which 
account for the discrepancy in the values obtained for the turnover of any 
metabolite include mixing of the label throughout the total pool. The 
total pool will consist of the plasma pool as well as any tissue pool to 
which label may be accessable. However, any metabolite which is con-
centrated within only one pool (i.e., the plasma) will have its label 
more quickly and simply dispersed than would one which is spread 
throughout various tissues. Such rapid dispersion of label will make 
the ln specific activity versus time curve approach the monoexponential 
form more quickly and allow a simple interpretation to be applied. Thus, 
while the bulk of the free glucose in the body is in the plasma and in-
terstitial fluids (73), the plasma glutamine pool forms less than 1% of 
the total body glutamine pool (Table 8). Therefore, while the application 
of the Zilversmit formula gives only minor differences from the constant 
infusion value for glucose, much larger discrepancies can be expected for 
glutamine. 
The pool size calculated by extrapolation of the linear portion of 
the ln. specific activity versus time curve back to zero (Table 6) 
can be compared to the total pool size of free glutamine in the rat 
(Table 7). Although the calculated pool size is only half as large as 
the total body pool, use of the nonlinear part of the curve in the 
determination of the pool size would give a larger calculated value. It 
is not known, however, if the calculated value would then be as large as 
- 90 -
the total body pool: 
(ii) Estimation of Errors. 
The estimation of the magnitude of the errors involved in the 
determination of turnover rates has been discussed by Hetenyi and Norwich 
(37). In an infusion experiment, the S.E.M. of the plateau specific 
activity divided by the plateau specific activity gives the fractional 
error in the turnover rate since random errors in the rate of ~nfusion 
are negligibly small. A regression analysis of the specific activity of 
the label in the plasma versus time should be done to determine if a 
steady plateau specific activity has been reached. In single injection 
experiments, error analysis is much more difficult since the accuracy of 
the turnover rate obtained depends not only on random errors but on the 
number of data points and weighting factors attached to each. No simple 
formula for the determination of fractional errors has been given. 
Errors in the value obtained for the turnover rate also arise from 
recirculation of label, i.e., from the resynthesis of labelled glutamine 
from labelled breakdown products. When this occurs, the value obtained 
for the turnover rate is lowered since when the label recirculates, it 
takes longer for all of the labelled substance to disappear from the 
system. As already discussed in the Introduction, it was hoped to 
minimize the recirculation -of labelled glutamine in our experiments by 
14 . the use of 1- C-labelled glutam1ne. However, it was noted in initial 
· f · · h 14c 1 · di · · d t · d 1n us1on exper1ments, w ere -g utam1ne ra oact1v1ty was e erm1ne 
by a modification of the method of Adam and Simpson (1), that as the 
infusion went on label in a neutral substance in the plasma samples in-
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creased. It was first thought that this substance could be urea, al-
14 tho,ugh treatment with urease (70) failed to release co2 from the in-
cubation mixture after acidification. Similar results were obtained using 
HCl and NaN02 (64), indicating that the labelled substance was not urea. 
Preliminary attempts using paper chromatography (24, 78) to deter-
mine. the identity of this substance were inconclusive. Whether the sub-
t ld · · 1 14c 1 · · · s ance cou g1ve r1se to - -g utam1ne 1s uncerta1n. 
The values for turnover rates of glutamine and other amino acids 
obtained by other authors have been mentioned in the Introduction. The 
values obtained in the constant infusion experiments agree well with those 
reported by Duda and Handler (25). Little difference in turnover rates 
of u-14c-glutamine has been reported in different acid-base states in 
sheep (35). 
B. Measurement of Arterio-Venous Differences Across All Organs 
. 
Arterio-venous difference measurements are a direct way of deter-
mining how an organ affects metabolites in the blood. Unfortunately, 
however, the variability found in blood metabolite levels in different 
animals introduces considerable random errors in the data. Calculated 
differences in the metabolite levels between different blood vessels must 
also have a considerable error, and a large number of experiments must be 
performed to determine significant arterio-venous differences. 
In our experiments metabolites were always measured in paired blood 
vessels from a single rat so that the arterio-venous differences thus 
calculated contain considerably less random errors. Nevertheless an 
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arterio-venous difference is usually the small difference between two 
large numbers and hence the error entailed may be large. For this 
reason it is quite possible that arterio-venous differences measured 
across many organs may not reveal statistically significant differences 
whereas the tissue in question may be actively metabolizing or pro-
ducing the substance being measured. 
Our experiments failed to identify the extra-renal source of the 
glutamine used by the kidney. Indeed there may be no extra glutamine as 
the turnover studies indicate, by both techniques, that the whole body 
turnover of glutamine is unchanged in acidosis. This implies that 
glutamine that would normally be used extra-renally is diverted to the 
kidneys in acidosis. An examination of the magnitude of the fluxes in-
volved is instructive. Using the most reliable turnover technique for 
glutamine, the constant infusion technique, the whole body metabolism of 
glutamine was estimated to be about 130 ~moles/hr/100 g body wt in both 
normal and acidotic rats (Table 6). Ammonia excretion in such acidotic 
rats averages about 2 mmoles/day/100 g body wt (58). Since only about 
half of the ammonia formed in the kidney enters the urine (the rest is 
taken away in the renal venous outflow) and since each glutamine molecule 
gives rise to two molecules of ammonia it can be calculated that the 
kidneys of such rats utilize about 2 mmoles of glutamine/day/100 g body 
wt or about 83 ~moles/hr/100 g body wt. Thus the renal utilization in 
acidosis is about two-thirds of the total turnover measured in normal 
animals. It is certain that an increased turnover of this magnitude 
would have been detected as can be seen from the relatively small 
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standard deviations of the estimates of turnover (Table 6). Since no 
such increase was observed it must be concluded that it did not take 
place. Hence, we conclude that the extra glutamine utilized by the 
acidotic kidney is at the expense of glutamine normally utilized by other 
tissues, i.e., no extra glutamine is formed. 
However, our experiments also failed to reveal which tissues used 
less glutamine. The tissues examined by arterio-venous difference were 
specifically chosen because of their importance in determining the over-
all .metabolism of the body. Thus, renal blood flow amounts to about 27% 
of the cardiac output, hepatic + G.I. tract to about 29%, brain to about 
15% and muscle (resting) to about 17%. These figures refer to man but 
the situation in all mammals is probably very similar. Thus, the vessels 
sampled accounted for 88% of the cardiac output in toto and thus should 
give a good quantitative picture of glutamine metabolism in vivo. 
Nevertheless, although the renal uptake was easily evident in the acidotic 
rats (Table 9), there was no tissue identified which utilized less 
glutamine. In fact, it can be suggested that no single such tissue 
exists since it would easily be identified in this analysis. This is so 
because the blood flows to all of the other regions sampled are either 
similar in magnitude (liver + G.I. tract) or less than (brain, muscle) 
the renal blood flow. Thus, any alteration in the metabolism of one of 
these tissues sufficiently large to account for the renal uptake during 
acidosis (either a decreased uptake or an increased output) would be 
sufficiently large to be identified by the arterio-venous difference 
measurements. Since none was detected it mu>t be assumed that altered 
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metabolism in no s~ngle tissue is responsible for the provision of 
glutamine to the kidney. The most likely hypothesis is that there is 
less glutamine utilization by all tissues except the kidney and that the 
sum of these deficits in utilization is sufficient to supply the extra 
glutamine required by the acidotic kidney. Since the sparing of 
glutamine is spread over a number of tissues the altered arterio-venous 
difference in any one tissue is insufficient to be observed experi-
mentally. The lower extra-renal utilization of glutamine is probably 
due to the lower blood concentration, which in turn is due to the in-
creased renal extraction. 
1. 
2. 
3. 
4. 
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